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Abstract
Hypersensitivity Pneumonitis (HP) is an interstitial lung disease caused by repeated inhalation of a wide
range of environmental antigens. It is characterized by alveolitis, granuloma formation, and fibrosis. Since
HP is a T cell-mediated disease, it is important to determine the type of T cell response associated with
granuloma formation and the factors that control this response. We hypothesized that HP is associated
with a predominant Th17 cell response where both T-bet and TLRs 2 and 9 are controlling T cell response
during HP. The results demonstrated a predominant Th17 response associated with granuloma formation
in the lungs of C57BL/6J mice during granulomatous and chronic HP. We also found that T-bet KO mice
exposed to Saccharopolyspora rectivirgula (SR) were characterized by exacerbated Th17 cell response
accompanied by an increase in granuloma formation and collagen production in the lungs compared to
WT exposed mice. In an attempt to find other factors regulating Th17 development, previous studies in
our lab showed that TLR2/9 double knockout (DKO) exposed mice were characterized by a decrease in
the percentage of Th17 cells in their lungs compared to WT mice. Consequently, we hypothesized that the
decrease in Th17 response is attributed to defect in phagocytosis, or cytokines production, or antigen
presentation ability of TLR2/9 DKO antigen presenting cells (APCs). In vitro, we found no significant
difference in the phagocytosis ability of both WT and TLR2/9 DKO BMDMs (Bone Marrow Derived
Macrophages) or BMDCs (Bone Marrow Derived Dendritic Cells). In vivo, there was no significant
difference in the phagocytosis ability of both WT and TLR2/9 DKO alveolar macrophages. Although we
found that both TLRs 2 and 9 were regulating cytokine production e.g. IL-6, IL-10, and TNFα from BMDMs,
we did not find a defect in antigen presentation ability of both WT and TLR2/9 DKO splenic APCs. In
conclusion, these findings suggested the following: (1) Both granulomatous and chronic HP is associated
with a predominant Th17 response and granuloma formation; (2) T-bet plays a role in controlling disease
severity and Th17 development during HP; (3) TLR2 and 9 do not affect APCs’ ability to phagocytose SR
but they affect cytokine production; and (4) Both WT and TLR2/9 DKO APCs are equally efficient in
presenting SR antigen to T cells.
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ABSTRACT
Hypersensitivity Pneumonitis (HP) is an interstitial lung disease caused by
repeated inhalation of a wide range of environmental antigens. It is characterized by
alveolitis, granuloma formation, and fibrosis. Since HP is a T cell-mediated disease, it is
important to determine the type of T cell response associated with granuloma formation
and the factors that control this response. We hypothesized that HP is associated with a
predominant Th17 cell response where both T-bet and TLRs 2 and 9 are controlling T
cell response during HP. The results demonstrated a predominant Th17 response
associated with granuloma formation in the lungs of C57BL/6J mice during
granulomatous and chronic HP. We also found that T-bet KO mice exposed to
Saccharopolyspora rectivirgula (SR) were characterized by exacerbated Th17 cell
response accompanied by an increase in granuloma formation and collagen production in
the lungs compared to WT exposed mice. In an attempt to find other factors regulating
Th17 development, previous studies in our lab showed that TLR2/9 double knockout
(DKO) exposed mice were characterized by a decrease in the percentage of Th17 cells in
their lungs compared to WT mice. Consequently, we hypothesized that the decrease in
Th17 response is attributed to defect in phagocytosis, or cytokines production, or antigen
presentation ability of TLR2/9 DKO antigen presenting cells (APCs). In vitro, we found
no significant difference in the phagocytosis ability of both WT and TLR2/9 DKO
BMDMs (Bone Marrow Derived Macrophages) or BMDCs (Bone Marrow Derived
Dendritic Cells). In vivo, there was no significant difference in the phagocytosis ability of
both WT and TLR2/9 DKO alveolar macrophages. Although we found that both TLRs 2
and 9 were regulating cytokine production e.g. IL-6, IL-10, and TNFD from BMDMs, we
did not find a defect in antigen presentation ability of both WT and TLR2/9 DKO splenic
APCs. In conclusion, these findings suggested the following: (1) Both granulomatous and
chronic HP is associated with a predominant Th17 response and granuloma formation;
(2) T-bet plays a role in controlling disease severity and Th17 development during HP;
(3) TLR2 and 9 do not affect APCs’ ability to phagocytose SR but they affect cytokine
production; and (4) Both WT and TLR2/9 DKO APCs are equally efficient in presenting
SR antigen to T cells.
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CHAPTER 1.

INTRODUCTION

Hypersensitivity Pneumonitis (HP) is an interstitial lung disease caused by
repeated inhalation of a wide range of environmental antigens. Alveolitis, granuloma
formation, and fibrosis are the hallmarks of the disease. Fibrosis is irreversible and
associated with significant morbidity and mortality. To date, the only available treatments
are corticosteroids and avoiding environmental antigen, and as such it is crucial to
understand the immunopathogenic mechanisms underlying the disease, which may lead
to development of novel therapies. Since several studies showed that HP is a
T cell-mediated disease, the main goals of our studies were as follows:
1- Investigate the T cell response (Th1 or Th17) during HP
2- Investigate the effect of T-bet (T helper 1 cell transcription factor) on
T cell response and disease severity during HP
3- Determine whether TLRs 2 and 9 in antigen presenting cells contribute
to the Th1 or Th17 response during HP
TYPES OF HYPERSENSITIVITY REACTIONS
During our daily life, we are exposed to a wide range of antigens from different
sources. The main function of our immune system is to deal with them in an appropriate
way without damaging the host. For example, infectious agents such as bacteria, viruses,
fungi, and parasites should be cleared efficiently by our immune system; while innocuous
agents such as pollen grains and foods should not induce an immune response. However,
in some circumstances a host will develop an exaggerated immune response against an
inciting agent and it is the immune response that causes pathology. Therefore, the patient
is hypersensitive against an inciting agent by developing hypersensitivity reaction.
Hypersensitivity reactions are mediated by both arms of adaptive immunity, i.e. humoral
immunity (antibody mediated) and cellular immunity (cell mediated). According to Gell
and Coombs, hypersensitivity reactions are classified into four types: Type I (immediate
hypersensitivity), II (cytotoxic hypersensitivity), III (immune complex mediated
hypersensitivity), and IV (delayed or cell-mediated hypersensitivity) [1]. Type I
Hypersensitivity is mediated by IgE antibodies, where hay fever or allergic asthma are
considered as the classic examples of this type of hypersensitivty. Type I Hypersensitivy
is initiated by activation of Th2 cells by allergens resulting in IgE production. IgE
antibodies bind to mast cells, sensitizing them to subsequent exposures. With subsequent
exposures, allergens bind to IgE on surface of mast cells causing degranulation of mast
cells and the release of histamines causing contraction of smooth muscles, vasodilatation,
and, increase in vascular permeability [2].
Type II hypersensitivity is mediated by IgG and IgM antibodies directed towards
target antigens on the cell surface. These antibodies bind to their antigens on cells and are
recognized by macrophages via their Fc receptors resulting in killing or cytolysis through
complement activation. Hemolytic anemia (destruction of RBCs) and thrombocytopenia
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(destruction of platelets) are the most common examples of type II hypersensitivity. Type
III hypersensitivity develops in sensitized individuals who have IgG directed against a
specific antigen. Upon subsequent exposure to the antigen the individual forms antibodyantigen immune complexes which get deposited in the tissues. Normally, large immune
complexes are cleared by phagocytes; however small immune complexes, such as those
that occur in type III are not phagocytosed and tend to deposit in blood vessels causing
tissue damage [2]. Type IV hypersensitivity is not mediated by antibodies as the previous
types; instead it is cell-mediated. The specific antigen is presented by antigen presenting
cells (APCs) to effector T cells, thereby stimulating cytokine release. The example of this
type is granulomatous inflammation which will be discussed in detail later on in this
chapter. The Tuberculin test is the most common example that exemplifies the sequence
of cellular events in Type IV Hypersensitivity. Intradermal injection of tuberculin
(carbohydrates and peptides from M. tuberculosis) elicits a T cell-mediated inflammatory
response caused by Th1 cells. Th1 cells secrete IFNJ and TNFE once they recognize the
antigen presented by APCs. These cytokines enhance expression of adhesion molecules
on the endothelium and increase vascular leakiness resulting in recruitment of plasma
cells and accessory cells [1]. Hypersensitivity Pneumonitis (HP) is classified under both
type III and type IV hypersensitivity [3, 4] for several reasons that will be discussed in
detail later in this chapter.
NAÏVE CD4+ T CELL DIFFERENTIATION
There are two types of immune response: innate (early) and adaptive (late)
immune response. Adaptive immunity is further classified into cell-mediated (T cells)
and humoral (antibodies secreted by B cells). T cells are divided into CD4+ T cells
(Helper T cells) and CD8+ T (Cytotoxic T cells) (Fig. 1-1). The term helper stems from
these T cells’ ability to help B cells for antibody class switching and activation of
macrophages. CD8+ T cells are called cytotoxic T cells since they directly kill host cells
infected with intracellular microorganisms by secretion of perforins and granzymes.
Once T cells are generated in the thymus (primary lymphoid organ), they exit to
the circulation as naïve T cells. Naïve CD4+ T cells have not yet encountered a foreign
antigen in their life cycle and they continuously circulate between blood and lymph nodes
(secondary lymphoid organs). If they encounter a foreign antigen in the lymph node, they
will become activated and differentiate into an effector CD4+ T cell. A naïve T cell only
encounters an antigen if it is presented by dendritic cells (DCs) in the lymph node. DCs
function to capture foreign antigens at the site of infection, process the antigen forming a
complex between the peptide and Major histocompatibility complex molecule class II
(MHCII) molecules then migrate to the draining lymph nodes to present the
antigen/MHC II complex to naïve CD4+ T cells [5]. During presentation, DCs provide
three signals to naïve T cells; signal 1 is processed antigen /MHC II complex engaging
antigen specific T cell receptor (TCR). Signal 2 is engagement of costimulatory
molecules; e.g. CD80 and CD86 by CD28 on the T cell [6] resulting in upregulation of
IL-2 production and hence T cell proliferation [7]. Signal 3 is cytokine stimulation that
directs naïve CD4+ T cells to differentiate into effector Th1, Th2, Th17, or iTregs cells
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Figure 1-1.

Types of immune response.

The immune response is divided into innate and adaptive immunity. Adaptive immunity
is further classified into cell-mediated and humoral immunity. Finally, both CD4+ and
CD8+ T cells are classified under cell-mediated immunity.
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(Fig. 1-2). In summary, the culmination of 3 signals leads to differentiation of naïve
T cells into effector T cells.
Each major subset of Th cells requires different cytokines and transcription
factors to regulate their differentiation. For Th1 cell differentiation, the master
transcription factor T-box expressed in T-cells (T-bet) is required for differentiation and
induction of IFNJ >@. Although the Th1 response is protective against intracellular
pathogens, excessive uncontrolled Th1 response leads to tissue inflammation and
autoimmune diseases. Although the name suggests that T-bet is only expressed in T cells,
other immune cells such as Dendritic cells [9], NK, and NKT cells [10] can also express
T-bet. During presentation to a naïve CD4 helper T cell, T-bet is induced by the
synergistic effect of T cell receptor engagement and IFNJ-STAT1 signaling. Induction of
T-bet expression stimulates expression of IFNJ and IL-12 receptor inducible chain
(IL-12RE2) which makes the T cells responsive to IL-12 and induces another wave of
T-bet expression stabilizing Th1 lineage [11-13]. The master transcription factor for Th2
cells is GATA3 which is induced by IL-4. The Th2 signature cytokines are IL-4, IL-5,
and IL-13 which are required for eosinophil recruitment and IgG and IgE class switching.
Th2 responses are important for extracellular pathogens and parasite clearance. IL-13 is
involved in mucosal activation (mucus hypersecretion), and therefore an excessive Th2
response is associated with asthma [14].
The master transcription factor(s) for Th17 effector T cells are Retinoid-related
Orphan Receptor (ROR) Jt and RORD. The combination of proinflammatory cytokine
IL-6 with immunoregulatory cytokine TGFE stimulates Th17 cell differentiation in mice
[15-18]. IL-6 and TGFE cooperate in induction of RORJt which is required for IL-17A
and IL-17F mRNA expression [19]. The signature cytokine for Th17 cells is IL-17 which
comes in several isoforms (IL-17A-IL-17F). In addition to IL-17, Th17 cells also secrete
IL-21 and IL-22 which are important in the overall Th17 response to pathogens [19-22].
Several studies demonstrated the protective role of Th17 effector cytokines in
extracellular and intracellular bacterial and fungal infections [23-28]. For instance,
IL-17A and IL-17 receptor Knockout mice are prone to K. pneumoniae infection [27, 28].
Furthermore, Th17 cells are also protective in Mycobacterium tuberculosis infections
indirectly, and IL-17 induces chemokines required for recruitment of protective Th1cells
[24]. Also, in F. tularensis live vaccine infection model, IL-17 induces IL-12 from
dendritic cells to establish a Th1 response and induces IL-12 and IFNJ from macrophages
to enhance bacterial killing [29]. Additionally, in acute respiratory tract infection caused
by Mycoplasma pneumoniae IL-17A and IL-17F derived from Th17 cells are important
in induction of lung neutrophil infiltration for pathogen clearance [25]. IL-22 also plays a
protective role in K. pneumonia and C. rodentium mouse infection model [28, 30]. In
K. pneumonia mouse infection model, neutralization of IL-22 increases the mortality rate
compared to WT mice. Also, mice treated with anti-IL-22 had a significant increase in
lung and spleen CFUs compared to WT mice [28]. Similarly, IL-22 KO mice infected
with C. rodentium are characterized by a significant decrease in survival rate compared to
WT mice [30]. In fungal infections, IL-17R A knockout mice are prone to Candida
albicans infection compared to their wild-type counterparts and the injection of IL-17A
into knockout mice protected them from lethal doses of infection [23]. Although Th17
4

Figure 1-2.
cells.

Differentiation of naïve T cell to different subsets of effector CD4+ T

Naïve CD4+ T cells require three signals to differentiate into effector CD4+ helper T cells.
Signals 1 and 2 come from T cell receptor and costimulatory receptors signaling. The
nature of the cytokine environment (signal 3) determines the fate of naïve CD4+ T cells.
IFNJ and IL-12 are required for Th1 differentiation, while IL-4 is required for Th2
differentiation. The combination of IL-6 and TGFE are required for Th17 cell
differentiation while TGFE is required for differentiation of naïve T cells to iTregs
(induced Tregs). Each subset of effector T helper cells has its own specific transcription
factor. T-bet, GATA3, RORJt and RORDand Foxp3 arespecific for Th1, Th2, Th17 and
iTregs respectively. The effector CD4+ T cells are characterized by their signature
cytokines. IFNJ is the hall mark cytokine for Th1 cells while IL-4, 5, and 13 are specific
for Th2. IL-17A, IL-17F, IL-21, and IL-22 are specific for Th17. (Adapted with
permission from Bettelli, E., et al., Induction and effector functions of T(H)17 cells.
Nature, 2008. 453(7198): p. 1051-7 [31].)

5

cells and cytokines play a protective role against numerous infections, several studies
demonstrated their pathogenicity as inducers of tissue inflammation in a number of
organ-specific autoimmune diseases such as Rheumatoid Arthritis, Multiple Sclerosis,
and inflammatory bowel disease [32-38]. In conclusion, Th17 cytokines protect against a
wide range of bacterial and fungal infections; however, Th17 cells can also play a
pathogenic role in certain circumstances.
Regulatory T cells (Tregs) play a crucial role in maintaining immunological
homeostasis and suppressing immune response. They are divided into two subsets,
Natural Tregs (nTregs) that develop in the thymus and induced Tregs (iTregs) derived
from peripheral naïve CD4+ T cells under the effect of TGFE and IL-2. Foxp3 is the
master transcription factor for Tregs and it is required for their suppressive function. Both
cytokines (IL-2 and TGFȕ) are required for maintenance of Foxp3 in Tregs and iTregs.
Mutations in Foxp3 causes a rare autoimmune disease IPEX (Immune-dysregulation
Polyendocrinopathy Enteropathy X-linked) in humans characterized by a variety of
inflammatory lesions in different tissues with massive production of Th1 and Th2
cytokines. Tregs use IL-2Ra (CD25) as a receptor for IL-2. Although they don’t produce
IL-2, they require IL-2 for their survival and expansion. They inhibit effector function of
T cells through several mechanisms, e.g., suppression by cytokines, cytolysis, metabolic
disruption, and targeting dendritic cells [14, 39-41].
GRANULOMA FORMATION
Definition
A granuloma is an organized mass of immune cells that mainly consists of
macrophages, dendritic cells, B cells, and T cells. Even though a granuloma is an
organized structure of cells, it is a dynamic microenvironment where immune cells are
recruited to or egressing from the granuloma under the influence of chemokines and
adhesion molecules. In addition, there is also cross-talk between the cells in the
granuloma resulting in activation of cells and cytokine secretion. The main function of a
granuloma is to wall-off the inciting agent from the surrounding tissue; however, if the
microorganism is persistent and the granulomas do not resolve, tissue damage and
eventually fibrosis occur giving granuloma characteristic of a double-edged
sword [42-44].
Requirements
Although granuloma consists of different types of immune cells, several studies
demonstrated the pivotal role of T cells in granuloma formation. RAG KO mice (mice
deficient in T and B cells) were unable to form liver granulomas around schistosome ova
and were unable to control bacterial dissemination or growth after mycobacterium
infection. Furthermore, adoptive transfer of CD4+ T cells into RAG KO mice infected
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with Schistosoma or mycobacterium causes granuloma formation [45]. Several studies
have shown the crucial role of CD4+ T cells in granuloma formation. HIV patients
(patients with low CD4 T cells counts) are vulnerable to intracellular pathogens that
require granuloma formation, such as M. tuberculosis, H. capsulatum, and Pneumocystis
carinii [46]. In the Tubercule bacilli (TB) mouse infection model, depletion of CD4+ T
cells leads to disorganized granuloma that results in reactivation and dissemination of
tuberculosis [47]. In the same line of evidence, mice lacking functional CD4+ T cells are
rendered susceptible to listeria infections which require granuloma for protection [48].
Additionally, depletion of CD4+ T cells in mice infected with Schistosoma mansoni
developed smaller granulomas and less fibrosis [49]. Intuitively, the repertoire of T cells
in the granuloma should be specific only to the antigen found at the site of inflammation;
however, there are a percentage of non-specific T cells recruited into the granuloma. For
example, in a S. mansoni mouse infection model, infection with LCMV (Lymphocytic
Choriomeningitis Virus) causes recruitment of LCMV-specific CD8+ T cells into
S. mansoni egg granuloma [50]. In summary, these studies have shown the importance of
T cells specifically CD4+ T cells in granuloma formation.
Cytokines and chemokines are also considered important requirements for
granuloma formation. Using a TB mouse infection model, several studies have shown the
importance of TNFD and IFNJ in the process of granuloma formation. The absence of
TNFD signaling causes a decrease in the number and size of granulomas [51, 52]. Also,
there is an increase in the mortality of TNFD KO infected mice compared to WT infected
mice [53]. Also, IFNJ KO mice fail to form granulomas following M. tuberculosis
infection [54]. In conclusion, both TNFD and IFNJ are important cytokines for
granuloma formation. It difficult to distinguish the role of TNFD whether in the initiation
or maintenance of granuloma since tissues were harvested at different time points
following TB infection. To get around this limitation, Clay et al. used an intravital
imaging system to track Mycobacterium marinum infected macrophages in zebra fish
embryos deficient in TNFD signaling [55]. The authors found normal recruitment of
macrophages to the site of infection in both WT and TNFD deficient zebra fish embryos
suggesting that TNFD is dispensable for granuloma formation. The next crucial
experiment was to determine if TNF is important for granuloma maintenance. Studies
using a chronic TB mouse infection model showed that neutralization of TNFD leads to
inability to maintain granuloma in the lungs [56, 57]. Furthermore, intravital imaging was
used in mice exposed to Mycobacterium bovis BCG. TNFD neutralization caused a
decrease in the size of granulomas since the trafficking of uninfected macrophages was
reduced [58]. In conclusion, TNFD plays a crucial role in granuloma maintenance, but
how does TNFD regulate granuloma maintenance? In one study, in vitro and in vivo
neutralization of TNFD downregulated chemokines secreted from macrophages and other
myeloid cells that may affect cell migration in and out of granuloma [56]. In conclusion,
both TNFD and IFNJ are important cytokines for granuloma formation.
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Granuloma as a Dynamic Environment
As mentioned before, granulomas are dynamic microenvironments where there
are immune cells infiltrating and egressing the granuloma. The number of cells in the
granuloma is determined by many factors. The balance between egression and infiltration
of immune cells is one and survival time, proliferation, and death of the immune cells are
other factors [42]. There are controversies regarding the role of TNFD in regulation of
cell death. Several studies showed that blockage of TNFD in murine models caused
macrophage apoptosis and major histopathological changes in the lung [52, 59]. In
contrast, in vitro TNFD induces apoptosis of human alveolar macrophages infected with
M. tuberculosis [60]. Using the Zebrafish M. muranium infection model, there was an
increase in granuloma non-apoptotic cell death in the absence of TNF signaling [55]. In
conclusion, TNFD plays a controversial role in regulation of cell death in granuloma.
The interaction between T cells and antigen presenting cells (APCs) is another
process that dictates the microenvironment in the granuloma. For example, DCs with
high expression of costimulatory molecules, MHCII and secretion of IL-12 were able to
induce IFNJ from Th1 cells which ultimately stimulates macrophages to kill TB, while
IL-10 secreting DCs with low costimulatory and MHCII expression were not able to
induce IFNJ from T cells supporting TB persistence within macrophages [44]. In
conclusion, the combination of several processes are required for granuloma formation;
the balance between egression and recruitment of cells, cytokines and chemokines,
survival of the cells within granuloma, and finally the cross-talk between the cells in the
granuloma.
Fate of Granuloma
The fate of a granuloma may be resolution by apoptosis or alternatively a failure
to resolve which may lead to fibrosis. Fibrosis is an uncontrolled wound repair process in
which damaged tissue is replaced by a fibrotic scar that ultimately impairs organ
function. The process is characterized by excessive production and accumulation of
extracellular matrix (ECM) proteins (e.g. collagen, proteoglycans, and fibronectins) from
myofibroblasts. It is a complex process that includes immune cells (T cells, macrophages,
and neutrophils), non-immune cells (epithelial cells, fibroblasts, myofibroblasts, and
fibrocytes), and proinflammatory and profibrotic mediators. TGFEis one of the
profibrotic cytokines that plays a central role in fibrosis, it induces fibroblast proliferation
and activation, production of ECM from myofibroblasts, and epithelial-mesenchymal
transition process (EMT), a process in which epithelial cells transform into fibroblast-like
cells [61]. Using bleomycin and farmer’s lung models, studies have shown that IL-17A,
and IL-17RA are involved in the process of pulmonary fibrosis in rodents [62] [63]. IFNJ
is considered an anti-fibrotic cytokine. In addition to being a transcription factor for Th1
differentiation T-bet is also a transcription factor for induction of IFNJin particular cells.
Numerous studies have also investigated the role of T-bet in fibrosis. T-bet KO mice
treated with bleomycin showed an increase in lung collagen content compared to WT
mice [64]. Furthermore, in the absence of T-bet mice had increased hydroxyproline in the
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skin following bleomycin treatment compared to WT counterparts [65].
HYPERSENSITIVITY PNEUMONITIS
History
In 1713, B. Ramazzini, an Italian medical professor, observed the health hazards
in grain workers and stated “Almost all who make a living by sifting or measuring grain
are short of breath and cachectic and rarely reach old age…” [3, 66]. With this
description he gave the first account for what is now known as Hypersensitivity
Pneumonitis (HP). In the 20th century, several published reports described outbreaks of
respiratory diseases that were later defined as HP. In 1932, the initial clinical description
of HP was developed following an outbreak of respiratory illness in a Michigan
Company. The workers were stripping bark from maple logs and developed symptoms
such as dyspnea, coughing, weight loss, and sputum. Similar symptoms appeared in
labors working with maple logs at a nearby sawmill. At both locales, investigators found
black dust lying beneath the bark from which they isolated a fungus called Cryptostroma
corticale [67]. The authors hypothesized that the symptoms resulted from an allergic
reaction to the spores of this microorganism. Another outbreak of respiratory disease was
reported among agricultural workers who also developed weight loss and dyspnea in
Northern England [68]. Once the workers ended their contact with hay, their symptoms
disappeared within several weeks. Twelve years later, similar conditions were recognized
and reported by W.N Pickles, a Yorkshire clinician. He referred to the condition as
farmer’s lung [66].
Different Types and Etiological Agents of HP
Hypersensitivity pneumonitis (HP) is an interstitial lung disease caused by
repeated inhalation of environmental antigens resulting in alveolitis, granuloma formation
and sometimes fibrosis [3, 69-71]. There are a wide range of environmental agents that
cause HP and they include animal proteins, fungi, and bacteria (Table 1-1). Each type of
HP is named after the antigen, occupation, or hobby performed by the exposed individual
[72]. For example, Farmer’s Lung Disease (FLD) is a classic example of HP caused by
repeated exposure to thermophilic bacteria called Saccharopolyspora rectivirgula (SR)
[73]. SR (rectus=straight and virgula=twig) is an aerobic thermophilic gram positive
spore-forming bacterium that belongs to the actinomycetes family. It has a type IV cell
wall which contains meso diaminopimelic acid (meso-DAP), galactose, and arabinose.
The bacteria grow in moldy hay as well as soil, compost, and manure [74]. When the hay
is disturbed, the spores become airborne and inhaled by farmers. In eastern France, other
organisms such as fungal species A. corymbifera, E. amstelodami, and W. sebi were
isolated from cowshed air and fodder and identified as potential etiological agents for
FLD in the absence of SR [75]. Different farming practices affect fungal and bacterial
concentration in hay and subsequently the disease risk [76]. Other types of HP include
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Table 1-1.

Different forms of HP showing putative antigens and their source.
Disease

Antigen source

Antigen

Bird fancier’s lung

Pigeon and parakeet

Avian proteins
in feces and feathers

Bagassosis

Moldy cane sugar

Thermophilic
actinomycetes

Cheese worker’s lung

Moldy cheese

Penicillium casei

Farmer’s lung

Moldy hay

Thermophilic
actinomycetes

Hot tub lung

Contaminated warm water

Mycobacterium avium

Malt worker’s lung

Moldy malt

Aspergillus sp.

Maple bark disease

Maple logs

Cryptostoroma corticle

Machine worker’s lung

Metal-cutting fluid

Mycobacterium sp. and
Gram-negative Bacilli

Tobacco worker’s lung

Moldy tobacco

Aspergillus sp.

Peat moss worker’s

Moldy peat moss

Penicillium sp.

Suberosis

Moldy cork

Aspergillus sp.

(Adapted with permission from Hirschmann, J.V., S.N. Pipavath, and J.D. Godwin,
Hypersensitivity pneumonitis: a historical, clinical, and radiologic review.
Radiographics, 2009. 29(7): p. 1921-38 and Dhar, S. and F. Daroowalla, Hypersenitivity
Pneumonitis. Clinical Pulmonary Medicine, 2011. 18(4): p. 169-174 [66, 77].)
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Bird Fancier’s Lung, which results from exposure to avian proteins found in feathers,
serum, or bird droppings [78]. Fungi are another source of HP antigens. For example,
members of the Aspergillus species induce disease among corn and malt workers [79,
80]. Also cheese, cork, and peat moss workers develop HP due to repeated exposure to
Penicillium species [81-83]. The enzyme phytase that is added to cattle feed and, also
molds from dry sausage have been described as a potential etiological agent for HP [84,
85]. Despite the wide range of etiological agents, all HP types are characterized by
alveolitis, and granuloma formation; some patients develop fibrosis, which is associated
with significant morbidity and mortality [86].
Classification, Clinical Diagnosis, and Epidemiology
HP Classification
HP can be classified into acute, subacute and chronic forms [87]. Acute HP is the
most common clinical presentation and is characterized by flu-like symptoms including
chills, malaise, fever and myalgias. Other pulmonary symptoms, including a nonproductive cough, chest tightness, or dyspnea may accompany the acute form. The
symptoms begin 2-9 hours after exposure and peak 6-24 hours after exposure then
resolve without any treatment 1-3 days post exposure cessation [88]. The subacute form
of HP is mainly characterized by a progressive cough, dyspnea, fatigue, weight loss, and
granuloma formation. The symptoms develop with continuous exposure and occur within
weeks to a few months of exposure [70, 89, 90]. The hallmark of chronic HP is
progressive, irreversible pulmonary fibrosis that takes months to years to develop, with a
mortality rate 1-10% [3]. There are conundrums surrounding this classification since
there is a lot of overlap between HP stages and no accepted criteria to distinguish
between the three stages. Recently, the classification of HP was revisited in a study [91].
The authors took advantage of a multicenter cohort HP study done between February
1998 and September 2001 from seven clinical sites in different countries and performed
cluster analysis to compare them to the current classification, i.e., acute, subacute, and
chronic [92]. The results from the cluster analysis did not confirm the current
classification, thus suggesting that HP patients are divided into two clusters. The first
cluster of patients develop chest tightness after antigen exposure, body aches, and chills,
with normal chest radiographs, while the second cluster is characterized by restrictive
pulmonary function tests, resting hypoxemia, and inspiratory crackles. One third of this
cluster develop fibrotic changes, as seen on High Resolution Computed Tomography
(HRCT) [91]. In conclusion, the current classification was not verified by this study in
which HP patients were classified into two categories rather than three; however, the
authors mentioned that their classification requires further validation.
HP Clinical Diagnosis
There is no solid standard diagnostic test to rule out HP from other interstitial
lung diseases [77]; however, a study proposed six diagnostic criteria for HP and when all
six factors are present the probability of HP is 98%. The six criteria are as follows:
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(1) Exposure to a known inciting agent, (2) loss of weight, (3) detection of precipitating
antibodies from patient sera, (4) on physical examination, inspiratory crackles are
present, (5) symptoms occur four to eight hours after exposure , and (6) the patient
experiences recurrent episodes of symptoms [92]. Chest X-ray is usually the first step in
the diagnosis of a patient with pulmonary disease. It mainly rules out other pulmonary
diseases rather than HP. Up to 20% of patients with acute HP have normal X-rays
[93].Usually the X-ray findings are not specific for HP showing the non-specificity of
this approach. Another diagnostic approach is the detection of serum-precipitating
antibodies. Several studies indicated that the presence of serum-precipitating antibodies
doesn’t really reflect the occurrence of HP. For instance, it has been reported that up to
50% of pigeon breeders and 30% of farmers develop serum-precipitating antibodies with
no evidence of disease symptoms [94, 95]. Furthermore, 78% of subjects exposed to
known antigens that cause HP had serum-precipitating antibodies while 38% of the
control group subjects were diagnosed with serum-precipitating antibodies [92].There are
several factors that contribute to the failure to detect serum-precipitating antibodies in a
given patient, they include usage of poorly purified antigens, lack of specificity, and
diluted serum patient samples [96]. The antibody concentration in the serum is low in HP
patients with smoking history [97-99]. In summary, serum-precipitating antibodies are
good markers against specific antigens; however, their absence does not negate diagnosis
with HP. Lung function tests are nonspecific for HP since the lung function changes are
similar to other interstitial lung diseases [90]. In general all forms of HP display
restrictive pattern of lung function, including reduced lung volumes and impairment in O2
transfer from airspace to blood (Diffusing Capacity of Lung for Carbon monoxide, DLco),
reduced compliance (the ability of the lungs to stretch back to their original size after
removal of a compressing force), and hypoxemia induced by exercise [100].Analysis of
the cellular composition of bronchoalveolar lavage (BAL) from patients is another tool to
diagnose HP. During BAL a saline solution is injected into the lungs and then retrieved
back to be examined by flow cytometry. In normal healthy subjects, 90% of the retrieved
cells are alveolar macrophages and the rest are lymphocytes, neutrophils and eosinophils
[101]. During an acute HP episode neutrophils are the main cell population in the BAL
within 48 hours of an exposure [102] which become lymphocytic later on.
The most effective way to manage HP is identifying the causative agent and
avoiding exposure to it; however, it is difficult to identify the inciting agent and adding to
that exposure cessation might put the patient’s daily work at risk. Complete cessation of
exposure may help acute HP patients to experience a reversal of symptoms, but once the
disease reaches the fibrotic stage it becomes irreversible. This results in significant
decline in lung function and can lead to death even if patients avoid exposure to the
inciting agent. Although corticosteroids are another option to improve lung function; it
does not replace the necessity of antigen identification and contact withdrawal [3, 77].
HP Epidemiology
The incidence and prevalence of HP are variable and hard to determine for several
reasons. The methods used to diagnose HP are limited, making HP often misdiagnosed as
viral pneumonitis or idiopathic interstitial disease [90]. Also, most HP studies were
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cross-sectional, while large scale surveys were few and mainly dependent on
questionnaire and detection of serum-precipitating antibodies [77, 103]. As mentioned
above, the presence of antibodies against specific antigen doesn’t rule out HP. The issue
gets more complicated by geographical, climatic conditions and farming practices.
Population studies have reported varying rates of HP incidence. In New Mexico, the
incidence of HP between 1988-1990 was 0.6 per 100,000 cases, whereas the incidence of
HP in Wisconsin dairy farmers was 42 per 100,000 [104, 105]. In the Czech Republic,
the most common types of HP were Farmer’s lung, Malt worker’s lung and Chemical
worker’s lung; however the incidence between 1992 and 2005 was only 0-0.2 per
100,000 workers[106]. In the UK, the most common types of HP were found in the
agriculture, fishing, and forestry industries and the incidence 1992 and 2001 was 1.6%.
[107]. Aside from the environmental factors and farming practices, genetic factors add
another layer of complexity in the epidemiology of HP. For example, certain alleles of
Major Histocompatibility Complex, TNFDpromoter, and LMP2 and 7 (encode subunits
in the proteosome complex for degradation of cytosolic proteins and generation of
antigenic peptides) are associated with Pigeon breeder’s disease [108, 109]. In
conclusion, combination of several factors is responsible for the variability in HP
incidence and prevalence.
Immunopathogenesis
Immunopathogenesis of HP in Patients
Despite the fact that a wide range of environmental agents may cause HP, the
disease is characterized by alveolitis, granuloma formation and fibrosis. In HP patients,
one of the hallmarks of the acute stage is neutrophilic alveolitis [102]. During acute HP,
the patients were diagnosed with a significant increase in the BAL cell numbers as well
as the percentage of neutrophils compared to control subjects [102]. Although CXCL2
(IL-8), a neutrophil chemokine, was detected in the BALF of HP patients [110, 111], the
source was not identified. Later on alveolar macrophages were discovered as the potential
source of IL-8 in HP patients [112]. The recruitment of neutrophils into the air space of
the lungs causes tissue damage through production of proteases and oxygen free radicals.
In patients with lung fibrosis, there was an increase in the number of lung neutrophils as
well as increase of matrix metalloproteinases (MMPs), MMP-8 and 9 compared to
control subjects [113]. The correlation between fibrosis and production of MMPs by
neutrophils suggested the role of neutrophils in tissue remodeling and eventually lung
fibrosis [113]. In conclusion, the previous studies suggested that AMs initiate
inflammatory environment in the air space by recruitment of neutrophils through IL-8
and they play a pathogenic role during fibrosis stage in HP.
CXCL2 is not the only chemokine produced by AMs. AMs isolated from HP
patients spontaneously produce an array of cytokines and chemokines, which eventually
contribute to macrophage and T cell recruitment and granuloma formation. For instance,
in acute and chronic HP patients, AMs produce increased amounts of IL-12, IL-18, and
TNFD without ex vivo stimulation compared to control subjects [114]. IFNJ stimulates
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macrophages to produce TNFD and IL-1E which further stimulates macrophages to
produce additional chemokines recruiting monocytes to the lungs for granuloma
formation [115]. Furthermore, IFNJ inducible chemokine CXCL10 is produced from
AMs isolated from HP patients. Consequently, CXCL10 recruits T cells bearing the
CXCR3 receptor especially CD8+ T cells into the lungs [116]. Additionally,
CCL3/MIP-1Dchemokine that contributes to recruitment of CD8+ T cells, was detected
in the BALF from HP patients [111]. Several studies demonstrated that CD8+ T cells
were the predominant T cells in the BAL of HP patients with acute and subacute stages,
decreasing CD4+/CD8+ ratio; however, in the fibrosis stage CD4+ T cells were elevated
increasing the CD4+/CD8+ ratio. These ratios could change based on the type of the
antigen [117-120]. Although AMs are considered as poor antigen presenting cells, AMs
isolated from HP patients are characterized by upregulation in HLA DR (MHCII) which
binds to the T cell receptor (TCR), co-stimulatory molecules (CD80 and CD86) which
bind to CD28 on the T cells, and Intracellular adhesion molecule-1 (ICAM-1) which
binds to Lymphocyte Function Associated antigen-1 (LFA-1) on T cells increasing
adhesion for T cell binding [121-123]. All these characteristics suggest they may be
important for T cell activation. In conclusion, AMs appear to contribute to production of
a wide range of cytokines and chemokines that create a proinflammatory environment
leading to recruitment of different immune cells and eventually granuloma formation.
Immunopathogenesis in an Experimental Animal Model
Although the previous HP studies can give us an appreciation for how disease
complexity, the studies are very limited regarding the number of samples and the
techniques used. Therefore, several animal models have been used to unravel the intricate
mechanisms behind the disease. The SR mouse model of HP mimics Farmer’s lung
disease, and in this model C57BL/6J mice are repeatedly intranasally exposed to SR.
Following one exposure there is a neutrophilic alveolitis that peaks at 24-48 hours
followed by lymphocytosis at 48-72 hours. Bronchoalveolar lavage fluid (BALF) is
characterized by an increase in proinflammatory cytokines and chemokines such as IL-6,
TNFD, IL-1D, CCL2 and CCL3 [124]. With continued exposures for 3 days per week for
three weeks the alveolitis becomes increasingly lymphocytic and there is the formation of
peribronchiolar granulomas [103]. The development of fibrosis with chronic exposures in
this model was an advantage for several studies to use and understand the role of
different cells and mediators in fibrosis during HP [62, 125, 126].
The wide range of proinflammatory cytokines and chemokines found in the
BALF could be produced by different types of cells in the lung following SR inhalation.
Alveolar macrophages might be potential candidates for production of these mediators. In
vitro stimulation of macrophages cell line (J744A.1) and murine alveolar macrophages
(AMs) with SR resulted in secretion of different cytokines and chemokines such as
CCL2, CCL3, IL-6, IL-12p40, TNFD, and IL-1D>@The combination of these
mediators create a proinflammatory environment in the airspace. One of the
consequences of a proinflammatory environment in the airspace is recruitment of
immune cells: neutrophils, monocytes, and T cells. Early neutrophilic influx into the
airways is one of the hallmarks of acute HP [102]. CXCL2 (mouse homologue for IL-8)
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was detected in the BALF of C57BL/6 mice following SR exposure; however, it was
significantly lower in the BALF of MyD88 KO mice (Adaptor protein downstream
TLRs) [127]. In the same line of evidence, SR stimulation of WT adherent spleen cells in
vitro induces CXCL2 production while MyD88 KO produces significantly less amount of
CXCL2 protein [127]. In summary, SR induces production of proinflammatory mediators
from lung cells e.g. alveolar macrophages resulting in a proinflammatory environment
and recruitment of immune cells into the lungs and airspace.
The continuous exposure to SR leads to recruitment of T cells and eventually
granuloma formation which is IFNJ dependent during HP [128]. However, the cellular
source of IFNJwas not identified at that period of time. Nance et al. identified
neutrophils as an important source of IFNJ required for granuloma formation [129]. IFNJ
induced recruitment of CXCR3+/ CD4+ T cells through induction of IFNJ inducible
chemokines I-TAC, MIG, and IP-10 during HP [130]. Furthermore, IFNJ mice
exposed to SR did not develop granulomas while WT counterpart did, demonstrating the
importance of IFNJ in granuloma formation during HP [128]. Since IL-10
(anti-inflammatory cytokine) antagonizes IFNJ biological actions, the role of IL-10 was
also examined during HP. Following three weeks of SR exposure, IL-10 KO mice
developed more alveolitis and lung inflammation compared to WT exposed mice. Also,
IL-10 KO mice were characterized by up regulation in the gene expression of TNFD,
IL-1, and IFNJ in the lungs compared to WT exposed mice. The replacement of IL-10 in
IL-10 KO exposed mice dampened the inflammation compared to IL-10 KO mice
without IL-10 replacement [131]. In summary, these data demonstrated that IFNJ and
IL-10 play a crucial role in the development of HP.
As described above various cytokines and chemokines were produced generating
a proinflammatory environment. TNFD is one of the proinflammatory cytokines that
plays a crucial role in various biological activities during inflammation, e.g. AMs’ and
neutrophils’ activation and stimulation of the endothelium. The role of TNFD during HP
was examined [126, 132-134]. Following three weeks of SR exposure, mice treated with
anti-TNFD were characterized by less inflammation in the airways and lung, down
regulation of IL-1 in BALF, and decreased collagen deposition in the lungs compared to
mice treated with control rabbit serum [126]. The decrease in lung collagen following
anti-TNFD suggested inhibition of TGFE (profibrotic cytokine that induce collagen
production) during HP. Consequently, levels of TGFE and collagen content were tested in
the lungs of C57BL/6 mice during HP. There was a significant increase in the levels of
lung TGFE following one week of SR exposure and increase in collagen content
following two weeks of SR exposure compared to saline exposed mice. Furthermore, in
vitro stimulation of alveolar macrophages from SR exposed mice produced significant
amounts of TGFE compared to AMs from saline exposed mice [125]. In conclusion, both
TNFD and TGFE are required for development of HP.
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HP as a T Cell-Mediated Disease
More than 40 years ago, HP was considered as an antibody-mediated disease
(Type III hypersensitivity reaction) in which the inhaled environmental antigen binds to
an antibody, forming antigen-antibody immune complexes. The deposition of these
immune complexes in the lung initiate the disease through activation of classical
complement pathway and alveolar macrophages secreting inflammatory cytokines;
hence, lung inflammation is initiated as discussed above. [99, 103]. However, several
observations during HP were not supported by this idea. First, granuloma formation and
lymphocytic bronchoalveolar lavage (BAL) support the notion that HP is indeed a
cell-mediated disease (Type IV hypersensitivity pneumonitis). Second, lack of vasculitis
(a hallmark of Type III hall marks) and failure to produce lesions similar to human
patients upon passive transfer of hyper immune serum [86, 103]. Third, the disease may
occur in individuals lacking antibodies [135]. Finally, asymptomatic individuals may also
develop antibodies aganist HP antigens [95]. In conclusion, these observations support
the importance of type IV hypersensitivity reaction over type III hypersensitivity reaction
during HP.
The discovery that humoral immunity (antibody mediated) does not play an
important role in HP pathogenesis led the HP research field to change its view toward the
disease and start to investigate the other arm of adaptive immunity, which is cellular
immunity. Numerous studies have demonstrated the importance of T cells in the
pathogenesis of the disease. C57BL/6 athymic nude mice (nu/nu), which lack T-cells,
develop less lung inflammation compared to (+/nu) mice when exposed to
Thermoactinomyces vulgaris, an HP causative agent [136]. To determine the role of
T cells in this model, nu/nu mice were injected with splenic T cells obtained from
sensitized +/nu-mice. The results demonstrated that the recipients develop lung
inflammation similar to +/nu-exposed mice, suggesting that T cells play a pathogenic
role [136]. However, it was unknown whether CD4+ or CD8+ T cells were responsible for
the disease. Schuyler et al. demonstrated that adoptive transfer of CD4+ T cells but not
CD8+ T cells from spleens or lung lymph nodes of SR sensitized mice into naïve mice
resulted in lung inflammation [137]. Similarly, adoptive transfer of CD4+ T cells into
TCREGdouble knockout mice (mice deficient in CD4+, CD8+ and JG T-cells) resulted in
lung inflammation and pulmonary fibrosis [62]. Finally, adoptive transfer of splenic cells
treated with anti-CD4+ antibody from SR sensitized mice failed to transfer the disease to
naïve animals [138] confirming the pathogenic role of CD4+ T cells during HP. In
conclusion, CD4+ T cells are pathogenic in HP.
Role of Th1 Cells and IFNJ during HP
Initial studies suggested that HP was a Th1 cell-mediated disease rather than a
Th2 cell-mediated disease. Th1 biased C57BL/6 mice are susceptible to HP while the
Th2 biased DBA/2 mice are resistant to HP [139, 140]. Also, GATA-3 knock-in
transgenic mice develop a less severe form of HP than their WT counterparts [141].
Additionally, based on pulmonary histological changes, it was found that CD4+ T cells
that adoptively transfer HP are Th1 but not Th2 cells [142]. Finally, knocking out
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IFNJthe Th1 signature cytokine protects SR exposed mice from granuloma formation
while WT SR exposed mice develop granuloma [128]. In conclusion, these studies
suggested that Th1 cells were important for the disease and that IFNJ was necessary for
granuloma formation. However, it was not clear whether IFNJ produced by Th1 cells is
required for disease severity during HP. Additional studies by our lab demonstrated that
adoptive transfer of T cells from IFNJ KO mice to RAG-1 KO mice (mice deficient in
T and B cells), followed by exposure to SR, resulted in the same level of disease severity
as adoptive transfer of WT T cells. These results demonstrated that T cell IFNJ
production was not necessary for the disease pathogenesis and that IFNJ production by
innate immune cells was sufficient. Therefore, the development of a Th1 response may
not be necessary for the development of the disease [129]. These data clearly demonstrate
that IFNJ produced by Th1 is not required for granuloma formation and a non-T cell
IFNJ source is sufficient for granuloma formation. Using intracellular cytokine staining,
the innate immune source of IFNJwas identified as neutrophils. Depletion of neutrophils
causes down-regulation of IFNJ at both the mRNA and protein levels, confirming the
importance of neutrophils as a significant source of IFNJ during HP [129]. In conclusion,
the previous studies suggested that HP was a Th1-mediated disease; however, IFNJ
produced by Th1 cells is not necessary for granuloma formation.
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CHAPTER 2.

HP AND TH17

While it was once thought that HP is a Th1 cell mediated disease, the results
demonstrating that IFNJ produced by Th1 cells was dispensable for granuloma formation
suggested otherwise. Consequently, we examined the T cell response during HP in an
attempt to determine whether a Th17 response rather than a Th1 response could be
responsible for the disease. The aim of these studies is to determine whether a Th17
response developed in the mice during the granulomatous and chronic phases of HP.
INTRODUCTION
Th17 Cell as a Distinct CD4+ T Helper Cell
The past few years have witnessed a revolution in the field of T helper cell
biology with the discovery of an additional effector T helper cell subset, Th17 cells.
These cells are characterized by their own distinct transcription factors, (RORJt and
RORD and signature cytokines (IL-17A, IL-17F, IL-21, and IL-22) [19-22]. Th17 cell
differentiation is induced by the combination of IL-6 and TGFE [15-18]. Both cytokines
cooperate together for induction of RORJt which is required for IL-17A and IL-17F
mRNA expression [19]. To further demonstrate the importance of IL-6 and TGFE in
Th17 differentiation, studies have shown that absence of TGFE receptor resulted in a
defect in generation of Th17 cells, while TGFE transgenic mice have a higher frequency
of Th17 cells following induction of Experimental Autoimmune Encephalomyelitis
(EAE, a mouse model for multiple sclerosis) [18, 143]. Similarly, IL-6 KO mice lack
Th17 cells; however, the dominant cell response is mediated by T regulatory cells (Tregs)
showing the inhibitory effect of IL-6 on TGFE driven Foxp3 expression. Nevertheless,
depletion of Tregs in IL-6 KO mice restores Th17 cell differentiation, indicating the
presence of another factor besides IL-6 for Th17 differentiation, IL-21 [144]. Since IL-21
is produced by Th17 cells, IL-21 in an autocrine manner, together with TGFE is able to
induce Th17 cell differentiation independently of IL-6 [144-146]. All the previous
characteristics made Th17 classified as a distinct subset of CD4+ helper T cells.
IL-23 is a member of the IL-12 family of cytokines that consists of 2 chains,
IL-23 p19 specific for IL-23 and the IL-12p40 that is common with IL-12 [147]. Since,
IL-23R is not expressed by naïve T cells, IL-23 is not involved in Th17 differentiation;
however, IL-23R is expressed on differentiated Th17 cells. In vitro data showed that
IL-23 is required for IL-17 secretion from Th17 cells but not for their proliferation and
commitment [148]. The role of IL-23 in several disease models was examined. For
example, it was shown that IL-23p19KO mice were protected from induction of EAE
[149]. Furthermore, Th17 cells cultured in vitro with IL-23 were able to transfer EAE
[150, 151]. These Th17 cells acquired pathogenic characteristics, whereas Th17
generated in presence of IL-6 and TGFE only were did not induce disease due to
anti-inflammatory cytokine IL-10 production [152]. Recently, this idea was supported by
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a study showing that naïve T cells cultured in the presence of IL-6, IL-1E, and IL-23
possess a pathogenic characteristic and able to transfer EAE to the mice via adoptive
transfer while culturing in the presence of IL-6 and TGFE only made them nonpathogenic [153]. More than 2,000 genes were differentially expressed between both
types of cells, showing that both have different expression profiles [153]. Although these
studies demonstrated the importance of IL-23 for Th17 pathogenicity in an autoimmune
disease model, the factor(s) downstream of IL-23 remained to be identified. Several
studies demonstrated that Granulocyte/Macrophage Colony Stimulating Factor
(GM-CSF) was produced by Th17 cells following IL-23 stimulation [150, 154, 155].
GM-CSF plays a pathogenic role in EAE. Neutralization of GM-CSF inhibits
development of EAE and enhances the recovery [155]. Antigen presenting cells express
the GM-CSF receptor whereas T cells do not and the main action of GM-CSF is to
upregulate MHCII and proinflammatory cytokines, e.g., IL-6. In EAE, GM-CSF deficient
mice have reduced MHCII expression on microglial cells [155] with less accumulation of
macrophages into the CNS [156]. Also, GM-CSF was shown to stimulate IL-23 from
dendritic cells, causing activation of Th17 cells and formation of IL-23-GM-CSF positive
feedback loop [154]. To conclude, IL-23 plays a role in the pathogenicity of Th17 cells.
Effector Function of Th17 Cytokines
Although IL-17 is considered the signature cytokine of Th17, it is expressed by
other immune cells [157-159]. IL-17 (also known as IL-17A) belongs to the IL-17 family
of cytokines which includes IL-17B-IL-17F members. It plays a role in host defense and
inflammation by induction of proinflammatory cytokines (IL-1, TNFD, and IL-6),
chemokines (CXCL1, CXCL2, CCL2, and CCL7), matrix metalloproteinases (MMP1, 3,
and 13) and antimicrobial peptides (defensins and S100 proteins). Furthermore, IL-17 is
involved in granulopoiesis and neutrophil recruitment by induction of G-CSF and
neutrophil chemokines such as CXCL2 [160]. Previous studies demonstrated the
correlation between IL-17 and airway neutrophil recruitment [161-163]. Administration
of exogenous IL-17 induced neutrophil recruitment as well as upregulation in neutrophil
chemokine, CXCL2 [161-163]. Following LPS intranasal administration, there was an
increase in IL-17 protein expression in the BALF accompanied by an influx of
neutrophils into the airways [162]. Moreover, IL-17 neutralization results in a decrease in
the number of airway neutrophils and CXCL2 protein expression in BALF [162] and
IL-8 secretion from 16HBE, human bronchoepithelial cells [161]. Taken together, these
studies emphasize the importance of IL-17 in regulation of neutrophil recruitment into
airways.
IL-22 is another cytokine secreted by Th17 cells, although it is also expressed by
a wide range of innate and adaptive immune cells e.g. NK cells, NKT cells, JG T cells,
dendritic cells, and CD8 T cells. The IL-22 receptor is expressed on nonhematopioetic
cells lining barrier surfaces such as lung, intestine, and skin as well as liver and kidneys
[164]. Several studies demonstrated the protective effect of IL-22 on airway and
intestinal epithelium through induction of antimicrobial peptides and enhancement of
epithelial barrier integrity [28, 30]. Also, IL-22 induces expression of chemokines and
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cytokines CXCL1, CXCL5, CXCL9, IL-6, and G-CSF required for host defense against
bacterial infection [28, 30]. Furthermore, IL-22 induces wound healing by increasing cell
migration in intestinal epithelial and keratinocyte in vitro wound assay [165, 166]. IL-22
also stimulates expression of antiapoptotic molecules e.g. BcL-2, BcL-xL as well as
protective mucin (muc1, muc3, muc10, and muc13) [164]. In a mouse model of
hypersensitivity pneumonitis, blocking IL-22 increases collagen deposition in the lungs
while injection of IL-22 prevents lung fibrosis. On the contrary, IL-22 promotes
pathological effects as well. For example, IL-23 stimulates dermal inflammation in an
IL-22 dependant fashion. In the same line of evidence, IL-22 KO mice were
characterized by decreased inflammation and epidermal hyperplasia in psoriasis mouse
model [167]. Furthermore, neutralization of IL-22 in psoriasis-like skin disease
ameliorates the disease severity and decreases expression of antimicrobial peptides [168].
To conclude, the previous results demonstrated the pathological and protective role of
IL-22 in different experimental animal models.
Is HP a Th1/Th17-Mediated Disease?
HP was once considered as a Th1 mediated disease for several reasons. Several
studies demonstrated the importance of Th1 cells in HP, while other studies demonstrated
the importance of the Th1 cytokine IFNJ IFNJ knockout mice (GKO) when exposed to
SR did not develop granulomas compared to the WT mice [128]. Previous results from
our lab demonstrated that T cell IFNJ production was not necessary for the disease and
that IFNJ production by innate immune cells was sufficient. Therefore, the development
of a Th1 response may not be necessary for the development of the disease [129].
However, since T cells are necessary for granuloma formation, is there is another CD4+
T cell subset, such as Th17 or Th2 cells, required for disease severity? The objective of
this chapter is to determine the T cell response (beside Th1 response) that develops
during the granulomatous and chronic phases of HP.
MATERIALS AND METHODS
Bacterial Preparation and Exposure Protocol
Bacterial Preparation
SR was obtained from the American Type Culture Collection (strain designation
A1313; ATCC, Rockville, MD). It is a thermophilic gram-positive bacterium formerly
known as Micropolyspora faeni belonging to the Pseudonocardiacecae family. The
bacterium was grown in Trypticase Soy Broth (BD; Sparks, MD) at 55oC in a shaking
incubator then harvested by centrifugation at 2000 rpm for 15 minutes and washed with
sterile endotoxin free water three times followed by lyophilization. The lyophilized
preparation was reconstituted at a concentration of 5mg/ml in endotoxin-free saline and
determined to be endotoxin free using the Limulus ambeocyte lysate assay (Lonza;
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Walkersville, MD). This preparation was used for intranasal exposures.
SR Exposure Protocol
Mice were anesthetized using isoflurane and SR (50-225Pg/ml) was inoculated
intranasally in a total volume of 40Pl. To study the innate immune response following
exposure to SR, mice were exposed once or twice and sacrificed 24 hours after the last
exposure. Studies on granuloma formation and the adaptive immune response were
performed after three weeks of exposure. Mice were intranasally exposed to SR on 3
consecutive days per week for three weeks (Fig. 2-1) and sacrificed 18 hours after the last
exposure (Day 18) or 4 days after the last exposure (Day 21). To examine the immune
response during chronic HP mice were intranasally inoculated with SR for 3 days per
week for 25 weeks. All experiments included unexposed mice or saline exposed as
negative controls.
Cell Culture Medium
RPMI (Cellgro, Mediatech Inc., Manassas, VA) containing 5% heat-inactivated
FCS (Hyclone; Rockford, IL), Glutamine (2mM), Penicillin/Streptomycin (100U/ml and
100Pg/ml) (GIBCO cell culture Invitrogen; Carlsbad, CA) and 2nM 2-Mercaptoethanol
(Fisher scientific; Pittsburgh, PA) was used in spleen and lung cell isolation experiments.
Bronchoalveolar Lavage (BAL) and Lung Cell Isolation
Mice were euthanized by CO2 asphyxiation and bronchoalveolar lavage (BAL)
was performed by intratracheal injection of 1 ml of PBS into the lung with immediate
aspiration. The amount of fluid recovered was routinely 70%-80%. To determine the
extent of alveolitis in individual mice the BAL cells were recovered by centrifugation and
live cells were counted using Trypan blue dye exclusion (Cellgro; Mediatech Inc.,
Manassas, VA). The BAL fluid was frozen at -80oC until used in Enzyme Linked
Immunosorbent Assay (ELISA) for cytokine and chemokine measurement.
To prepare single lung cell suspensions, lungs were perfused with sterile PBS to
remove circulatory cells and lung lobes were removed. The lung lobes were minced into
small pieces and digested with Collagenease 20U/ml and Deoxyribonuclease I 40Pg/ml
(Sigma-Aldrich, St. Louis, MO) for 45 minutes at 37oC. The digested tissue was
disrupted using a Stomacher® 80 tissue processor (Brinkman Instruments, Westbury,
Day
SR exposure
Figure 2-1.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Three week SR exposure.
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NY) and debris removed by passage through a 70PM strainer (BD falcon). The cell
suspension was layered on a discontinuous gradient consisting of 40% and 80% percoll
(Sigma-Aldrich, St. Louis, MO). The cells were collected at the 40% - 80% percoll
interface following centrifugation at 2000 rpm for 20 minutes. The cells were washed
with sterile PBS and live cells counted using Trypan Blue exclusion dye.
RNA Extraction and Semi-Quantitative RT-PCR
RNA Extraction
Total RNA was extracted from one lung lobe of individual mice using Trizol®
(Invitrogen, Carlsbad, CA). Contaminating genomic DNA was removed by treating the
RNA samples with DNase (Turbo DNA free, Ambion, Austin, TX). RNA concentration
was determined by measuring the absorbance of UV light at 260nm, and 280nm using
Ultraspec 2000 spectrophotometer (Pharmacia Biotech, Piscataway, NJ). The
concentration of RNA (μg/ml) was calculated by multiplying the absorbance (A260), the
dilution factor and 40μg/ml. To determine the quality of the RNA 1-2Pg were loaded on
a 4% agarose gel and analyzed for the presence of 18S and 28S ribosomal RNA subunits
as an indicator of intact RNA.
Semi-Quantitative RT-PCR
Two Pg of RNA from individual samples was reverse transcribed into cDNA
using a Promega Reverse Transcription System kit following manufacturer’s instructions
(Promega, Madison, WI). The cDNA synthesized from RNA was used as a template for
end point PCR to be amplified using Taq Polymerase (Promega, Madison, WI). For
semi-quantitave PCR, each PCR cycle was run with a denaturation step at 95oC for 30
seconds, followed by an annealing step at a primer-specific temperature (Table 2-1) for
30 seconds and an extension step at 72oC for 30 seconds. All the reactions were amplified
for 35 cycles, except for E-actin, which was amplified for 28 cycles. After amplification
20Pl of product were loaded on a 1.8% agarose gel to be separated by agarose gel
electrophoresis. The separated bands were visualized using ethidum bromide staining and
were detected using an Alpha Image 2200 Multi-image light cabinet and alphaEase FC
software (Alpha Innotech Corporation, San Leandro, CA).
Flow Cytometry
Cell Surface Staining
Phenotyping of BAL cells and lung cells was performed using flow cytometry.
Cells (2x105cells/tube) were incubated for 15 minutes on ice with 0.1Pg/ml Fc block
(Anti-CD16/CD32 antibody) [BD Biosciences, San Diego, CA] to block Fc receptors.
The cells were washed with 1ml FACS Buffer (PBS + 3%FCS) and centrifuged for 5
minutes at 1500 rpm. The cell pellet was resuspended in approximately 200ȝl FACS
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Table 2-1.

List of PCR primers used for PCR.

Primer
name

Forward
primer

Reverse
primer

Product
length
(bp)

Anneal.
temp.
(oC)

IL-4

TCG GCA TTT TGA
ACG AGG TC

GAA AAG CCC GAA
AGA GTC TC

261

60

IL-6

GAC AAA GCC AGA
GTC CTT CAG AGA G

CTA GGT TTG CCG
AGT AGA TCT C

229

60

IL-17

CTC CAG AAG GCC
CTC AGA CTA C

AGC TTT CCC TCC
GCA TTG ACA CAG

142

60

IFNȖ

TCA AGT GGC ATA
GAT GTG GAA GAA

TGG CTC TGC AGG
ATT TTC ATG

92

60

CXCL2

TGG GTG GGA TGT
AGC TAG TTC C

GT TTG CCT TGA
CCC TGA AGC C

285

65

T-bet

GCC AGG GAA CCG
CTT ATA TG

GAC GAT CAT CTG
GGT CAC ATT GT

136

60.2

Human
RORJt

CCG CTG AGA GGG
CTT CAC

TGC AGG AGT AGG
CCA CAT TAC

110

60

E-Actin

GTG GGC CGC TCT
AGG CAC CA

CGG TTG GCC TTA
GGG TTC AGG
GGGG

245

60
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buffer and incubated with fluorochrome-conjugated antibodies specific for surface
markers (Table 2-2) for 30 min on ice in the dark. The cells were washed twice with
FACS Buffer and resuspended in a final volume of 200ȝl FACS Buffer prior to analysis
using a BD LSRII (BD, San Diego, CA) flow cytometer. Approximately, 30,000 to
50,000 events/tube were collected and the data was analyzed using FACSDiva Software
(version 5.02).
Preparation of Bacterial Lysate for Intracellular Cytokine Staining
SR lysate was prepared by using Y-PER reagent (PIERCE, Rockford, IL). One
gm of lyophilized SR was incubated with 7.5ml of Y-PER reagent for 20 minutes at room
temperature with gentle rocking followed by three cycles of freeze and thaw 5 minutes
each. The bacterial suspension was centrifuged at 8500rpm for 5 minutes at 4°C and the
supernatant collected. The SR lysate was diluted in 10-20 volumes of PBS to remove
SDS and concentrated using Y-10 concentrators (Millipore; Billerica, MA). The protein
concentration in the SR lysate was measured using Bio-Rad protein assay following
manufacturer’s instructions (Bio-Rad Laboratories; Hercules, CA).
Intracellular Cytokine Staining
Intracellular cytokine staining was used to identify Th1 and Th17 cells. For Th1
or Th17 cell determination, lung cells were isolated from mice exposed to SR for three
weeks. In a 96 well plate, at least 2x105cells/well were plated and stimulated with media,
SR lysate (20ȝg/ml), or anti-CD3 antibody (10ȝg/ml) for 7 hrs at 37°C. Golgi plug (BD
Biosciences, San Diego, CA) was added for the final 4 hours of the culture to inhibit
protein secretion. Cells were harvested and cell surface staining performed using
antibodies to CD4, ETCR, and CD11b. Cells were fixed using Pl BD Cytofix (BD
Biosciences, San Diego, CA) for 15 minutes on ice and washed twice with
permeabilization washing buffer (0.5% BSA + 0.5% Saponin in PBS). The cells were
incubated with anti-IFNJ, anti-IL-17, or anti-IL-6 antibody for 30-45 minutes on ice,
washed twice and analyzed on the BD LSRII.
Histology
The perfused left lung lobe was harvested and fixed overnight in neutral buffered
formalin at 4oC. The lung tissue was embedded in paraffin and sectioned into 8 Pm
sections and stained with Hematoxylin and Eosin (H&E) by the Department of
Pathology, UTHSC.
Statistical Analysis
Values were expressed as means ±SD. For comparison of means between two
populations of unpaired data, unpaired student’s t-test was used. For comparison between
more than two groups, One-way ANOVA followed by Tukey’s post ANOVA test was
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Table 2-2.
Characterization of innate and adaptive immune cell surface and
intracellular markers.
Cell population

Cell markers

Neutrophils

CD45+, CD11b+, Gr-1hi or
Ly6G+

Alveolar macrophages

CD45+, CD11c+, CD11b-,
CD205+, F4/80+

Interstitial macrophages

CD45+, CD11c-, F4/80+

NK cells

CD45+, NK1.1+

T cells

CD45+, TCRE+

CD4 T cells

CD45+, TCRE+ , CD4+

CD8 T cells

CD45+, TCRE+ , CD8+

TH1

CD45+, TCRE+ , CD4+, IFNJ+

TH17

CD45+, TCRE+ , CD4+, IL-17+
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used. GraphPad Prism 5 was used to perform all tests. Differences were considered
significant at P <0.05.
RESULTS
Characterization of BAL Composition during Acute HP
Measurement of alveolitis and characterization of BAL cellular composition are
parameters to assess disease severity during HP. We analyzed the cell population in the
airways by exposing C57BL/6J mice to SR. Following two daily exposures of SR (50 Pg
each), mice were sacrificed and BAL was performed. Cells were collected and counted
for phenotypic characterization by flow cytometry. In exposed mice, we found a
significant increase in alveolitis compared to unexposed control mice. Furthermore, there
was an influx of neutrophils which represent approximately 80% of the total cells in the
airways but there was no difference in the percentage of NK cells between SR exposed
and unexposed mice (Table 2-3). In conclusion, acute HP is characterized by neutrophilic
alveolitis.
Expression of IL-17 and CXCL2 during Acute Phase of HP
In the previous section, we demonstrated that acute HP was associated with
neutrophilic alveolitis. Since IL-17 has been demonstrated to induce neutrophil
Table 2-3.
C57BL/6J mice develop alveolitis and airway neutrophilia following
acute exposure to SR compared to unexposed mice.
Mice

Alveolitisa (±SD)

PMNb % (±SD)

NK cellsb %
(±SD)

Unexposed
C57BL/6J
Exposed
C57BL/6J

0.19x106 (±0.14)

1.57 (±0.9)

0.5 (±0.38)

2.15x106 (±0.6)**

77.45 (±7.1)***

1.55 (±0.46)

C57BL/6J mice (n=3-4/group) were exposed to SR twice (50Pg each).
a
BAL was performed and recovered cells were counted using Trypan Blue dye exclusion
to exclude dead cells
b
Cells isolated from the BAL fluid were incubated with antibodies to various cell surface
markers and analyzed by flow cytometry to determine cellular composition of the BALF.
PMNs were identified as CD11b+/Gr-1hi. NK cells were identified as NK1.1+ cells.
Results were expressed as means ±SD. Using unpaired student’s t-test, the mean of the
unexposed group was compared to the exposed group. (**P<0.005 and ***P<0.0001
significant difference from the unexposed group.)
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chemokines e.g. CXCL1, CXCL2, and CXCL5 [161-163], we investigated whether there
was an upregulation in IL-17 mRNA expression accompanied by upregulation in
neutrophil chemokine (CXCL2) and neutrophilic alveolitis during acute HP. To fulfill
this aim, mice were exposed twice daily to 50μg SR and lung IL-17 and CXCL2 mRNA
expression were analyzed by semi-quantitative RT-PCR. RNA was isolated from lung
homogenates of individual mice, reverse transcribed into cDNA and PCR was performed
using primers specific for CXCL2 and IL-17. The results demonstrated that both IL-17
and CXCL2 mRNA expression increased following SR exposure as compared to
unexposed mice (Fig. 2-2). These data demonstrated a correlation between neutrophil
influx and IL-17 expression.
Acute HP Is Associated with Th17 Differentiation and Effector Cytokines
Several disease models associated with Th17 response were characterized by a
neutrophil-rich environment [169, 170]. During acute HP, we determined that HP is
associated with IL-17 upregulation and neutrophilic alveolitis suggesting that HP is a
Th17-mediated disease. Therefore, we examined the cytokines associated with Th17
response as well as its differentiation to determine whether they were present during the
acute phase of HP. To fulfill this aim, C57BL/6J mice were exposed one time to 100Pg
SR and cytokine expression was analyzed by semi-quantitative RT-PCR. RNA was
isolated from lung homogenates from individual mice 1, 3, 6, and 24 hours after SR
exposure then reverse transcribed into cDNA to perform PCR using primers specific for
IL-6, IL-21, IL-22 and IL-23. The housekeeping gene E-actin was used as an internal
control. We found an upregulation in the proinflammatory cytokine IL-6 that is required
for Th17 differentiation along with TGFE (Fig. 2-3). IL-6 was upregulated at 1 hour post
SR exposure and then it was downregulated at 24 hours. We found a slight upregulation
in IL-22 which started following three hours of SR exposure. There was a weak
expression in IL-21. Our data demonstrated weak expression of IL-23p19 which started
at three hours and decreased by 24 hours. In conclusion, these results demonstrated the
presence of cytokines associated with Th17 response and differentiation during acute HP.
Characterization of BAL Composition during Granulomatous HP
Continuous exposure to SR results in a disease shift towards the granulomatous
stage. The hallmarks of the granulomatous phase of HP are granuloma formation in the
peribronchiolar areas of the lungs and lymphocytic alveolitis. In contrast to acute HP, in
granulomatous HP we found that neutrophils represented approximately 15% (±1.32) of
the total BAL composition; however, T cells represent 26% (±6.2) of the total cells while
CD4+ T cells represented 18% (±4.9) of the total cells (Table 2-4). There was no
difference in the percentage of NK cells. In conclusion, the results demonstrated a
lymphocytic rather than neutrophilic alveolitis during granulomatous HP.
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Figure 2-2.

Expression of IL-17 and CXCL2 (MIP-2) during acute HP.

C57BL/6J mice (4/group) were exposed two times to SR (50Pg). Total RNA was
extracted from one lung lobe of individual unexposed and exposed mice then reverse
transcribed into cDNA to use in RT- PCR using primers specific for IL-17 and CXCL2.
The housekeeping gene E-actin was used as an internal control.

Figure 2-3.

mRNA expression of Th17 cytokines during acute HP.

C57BL/6J mice (n=3) were exposed to100Pg SR then sacrificed after 1, 3, 6, or 24 hrs.
Total RNA was extracted from one lung lobe of unexposed and exposed SR individual
mice then reverse transcribed into cDNA to use in RT- PCR using primers specific for
IL-6, IL-21, IL-22 and IL-23p19. The housekeeping geneE-actin was used as an internal
control.
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Table 2-4.
HP.

C57BL/6J mice develop lymphocytic alveolitis during granulomatous

Mice

Alveolitisa
(±SD)

PMNb
% (±SD)

NK cellsb
% (±SD)

T cellsb
% (±SD)

CD4+
T cellsb
% (±SD)

Unexposed
C57BL/6J

0.3x106
(±0.13)

1.66
(±0.71)

15
(±0.38)

4.8
(±0.92)

4.03
(±0.7)

SR
Exposed
C57BL/6J

5x106
(±1.6)**

14.9
(±1.32)***

13.9
(±4.2)

25.96
(±6.2)**

18.4
(±4.9)**

C57BL/6J mice (n=3/group) were exposed to SR (200Pg each) three times a week for
three weeks then sacrificed 4 days following last exposure.
a
BAL was performed and recovered cells were counted using Trypan Blue dye
exclusion.
b
Cells isolated from the BAL fluid were incubated with antibodies to various cell surface
markers and analyzed by flow cytometry to determine cellular composition of the BALF.
PMNs were identified as CD11b+/Gr-1hi. NK cells were identified as NK1.1+ cells. T
cells were identified as TCRECD4+ T cells were identified as TCRECD4+. Results
were expressed as means ±SD. Using unpaired student’s t-test, the mean of the
unexposed group was compared to the exposed group. ( P<and P,
significant difference from the unexposed group.)
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Granuloma Formation during Granulamatous HP
One of the hallmarks of HP is granuloma formation that is typically found in the
peribronchiolar regions. To demonstrate that mice exposed to SR for three weeks develop
this form of the disease, H&E staining was performed on lung lobes isolated from
exposed and unexposed mice (Fig. 2-4). The results demonstrated peribronchiolar
granuloma in the lung interstitum. At this time point, if exposures were stopped, the
granulomas resolved and the lung returned to normal (Fitzpatrick unpublished data).
Granulomatous HP Is Associated with Activated CD4+ T Cells
Granuloma formation in HP is T cell dependent; therefore, we examined the
phenotype and activation state of the cells infiltrating the lung after 3 weeks of SR
exposure. Following 3 weeks of SR exposure, unexposed or SR exposed mice were
sacrificed at 4 days following last exposure. We isolated lung cells from mice exposed to
SR for 3 weeks to determine the percentage and activation status of the T cells as well as
innate cells. Single lung cell suspensions were prepared and incubated with
fluorochrome conjugated antibodies to CD45, NK1.1, Gr-1, CD4, TCRE chain, the early
activation marker CD69 and CD25 (IL-2DR, IL-2 high affinity receptor subunit).

B

A

Figure 2-4.
exposure.

Peribronchiolar granuloma formation following 3 weeks of SR

Following 3 weeks of SR exposure, C57BL/6J mice were sacrificed and one lung lobe
was used for H&E staining. Staining lung sections from unexposed or SR exposed mice
showed granuloma formation in the exposed mice (Original magnification 63X). Panel A
represents lung section from unexposed mouse. Panel B represents lung section from SR
exposed mouse.
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The results demonstrated an increase in the percentage of T cells (16% ±3.6) in
the lungs of exposed mice compared to unexposed mice (13% ±1.8) (Fig. 2-5). Also,
there was an increase in CD4+ T cells (13% ±3.1) in the lungs of SR exposed mice
compared to unexposed mice (7.5% ±1.6). Furthermore, the CD4+ T cells from exposed
mice were activated as measured by expression of the activation marker CD69. SR
exposed mice showed a signficant increase in the percentage of CD4+/CD69+ T cells
compared to unexposed mice (6% ±2.2 Vs. 0.7% ±0.2). However, we did not detect a
signficant difference in CD25 (IL-2R) expression between unexposed and exposed
groups. Interestingly, there was a signficant decrease in the percentage of NK cells in
exposed mice compared to unexposed mice although this may be a dilutional effect.
Finally, there was no difference in the percentage of PMNs between unexposed and SR
exposed mice. In conclusion, granulomatous HP is associated with activated CD4+ T cells
in the lungs.
Granulomatous HP Is Associated with Th17 Immune Response
In the previous section we found an influx of activated CD4+ T cells into the
lungs; however, we do not know the type of these cells, i.e., Th1, Th2, or Th17. To
determine the type of these cells, we used semi-quantitative RT-PCR to measure
expression of T cell differentiation factors and cytokines. Following three weeks of SR
exposure, total RNA was isolated from individual lung lobes of exposed mice as well as
unexposed mice. Semi-quantitative RT-PCR was performed using primers for the Th1
cytokine IFNJ and the Th1transcription factor T-bet, the Th2 cytokine IL-4, Th17
cytokine IL-17 and Th17 transcription factor RORJt.
The results demonstrated a faint band for IL-4 in 2 / 3 exposed mice suggesting
there was not much of a Th2 response developing at this time point. IFNJmRNA was
increased in the exposed mice compared to the unexposed mice, demonstrating that this
cytokine is associated with granulomatous inflammation; however, the Th1 transcription
factor T-bet did not increase at the time points we examined. Since, both IL-17 and the
Th17 transcription factor RORJt expression were upregulated, these data suggest the
development of Th17 response during this stage of the disease (Fig. 2-6).
The upregulation of IL-17 and RORJt mRNA in the lung homogenates suggested
that Th17 cells had migrated into the lungs following SR exposure. In order to measure
the frequency of Th1 and Th17 cells in the lungs, we performed intracellular cytokine
staining. Mice were exposed to SR for 3 weeks and then lung cells were isolated and
stimulated ex vivo with media or SR lysate for 6 hrs. Flow cytometry was performed
using antibodies against CD45, CD4, IL-17 and IFNJ We found an average of 16% ±1.7
Th17 cells and 1.1% ±0.3 Th1 cells in the lungs of SR exposed mice following ex vivo
SR stimulation and an average of 0.36% ±0.15 Th17 cells vs. 0.33% ±0.3 Th1 cells in
presence of media only. We also detected approximately 0.52% ±0.2 IFNJ+/IL-17+ CD4+
T cells following SR stimulation (Fig. 2-7). In conclusion, granulomatous HP is
associated predominately with a Th17 response and a low frequency of Th1 cells
confirming the semi-quantitative RT-PCR results.
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Figure 2-5. Cell surface staining showing the average percentage of different cell
populations in the lung interstium of unexposed and SR exposed mice following 3
weeks of SR exposure.
Total immune lung cells were isolated from unexposed (n=3) and exposed mice (200Pg
SR for 3 weeks of exposure) then sacrificed 4 days later. Cells were stained for CD45,
NK1.1, CD11b, TCRE, CD4, CD69, and CD25. Data was acquired on LSRII using FACS
Diva Software. Approximately, 25,000 - 30,000 events were collected. Cells were gated
as follows for NK cells CD45+/NK1.1+, PMNs CD45+/CD11b+/Gr-1hi , T cells
CD45/TCRE+, CD4+ T cells CD45+/TCRE+/CD4+, activated T cells as
CD45+/TCRE+/CD4+/CD69+ or CD25+. Results were expressed as means ±SD. Using
unpaired student’s t-test, mean of the unexposed group was compared to the exposed
group. (*P<0.02 and **P<0.002, significant difference from unexposed group.)
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Figure 2-6. mRNA expression of different cytokines and T cell transcription
factors from unexposed and SR exposed mice during granulomatous HP.
C57BL/6J mice (n=3) were exposed to 200Pg SR for three weeks then sacrificed 4 days
following last exposure. Unexposed mice were used also as controls. Total RNA was
extracted from one lung lobe of individual mice and reverse transcribed into cDNA to use
in semi-quantitative RT- PCR using primers specific for IL-4, IFNJ, IL-17, RORJt, and
T-bet. The housekeeping gene E-actin was used as an internal control.
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(A)

(B)

Figure 2-7.
Intracellular cytokine staining showing percentage of Th1 and Th17
cells in the lungs following 3 weeks of SR exposed mice.
Mice (n=5) exposed to100Pg SR for three weeks, then lung cells were isolated and
stimulated in a 96 well plate (5x105 cells/well) ex vivo either with media or 20Pg SR
lysate for 3 hours followed by 3 hours of golgi plug at 37°C to accumulate cytokines
inside the cell. Cells were stained for CD45, CD4, IL-17, and IFNJ $ Representative
flow cytometry dot plot of IL-17 and IFNJ expression by intracellular cytokine staining
showed an increase in Th17 cells from the lungs of SR exposed mouse following SR ex
vivo stimulation. (B) $verage percentage of Th1, Th17, and IFNJ/IL-17+ CD4+ T cells.
Results were expressed as means ±SD. One way ANOVA followed by Tukey’s post
ANOVA test was used to compare means of all groups. (***P<0.0001.)
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Characterization of BALF during Chronic HP
The previous results suggested that a predominant Th17 response was associated
with granulomatous HP; however, this phase resolves and the lung returns to normal if
the exposures are stopped (Fitzpatrick unpublished data). During the chronic form of HP,
the granulomas become fibrotic and the disease does not resolve even if the exposures are
stopped. This form of HP is associated with significant morbidity and mortality. To
determine if the Th17 response is associated with this more severe phase or if the disease
has switched to become more of a Th2 or Th1 response, we examined the T cell response
following chronic exposure to SR. First, we characterized the compostion of BAL cells
during the chronic phase of HP. Following 25 weeks of SR exposure, mice developed
alveolitis which was mainly composed of neutrophils showing neutrophil influx during
the chronic phase. Neutrophils represent 75% of the total cell in the airways compared to
1.25% in the unexposed mice. For T cells, there was an increase in the percentage of total
T cells where CD4+ T cells constituted 50% of total T cells. Although, the percentage of
NK cells in the BAL of unexposed mice is higher than exposed mice, their actual
numbers are aproximately equal. Finally, there was not an increase in the percentage of
CD8 T cells but the actual numbers of CD8+ T cells higher in the WT exposed mice
compared to unexposed mice (Table 2-5).
Chronic HP Is Associated with Granuloma Formation
We analyzed granuloma formation during the chronic phase of the disease and
found the granulomas were still located in the peribronchiolar region. As shown in
Fig. 2-8, following 25 weeks of SR exposure, there was peribronchiolar granuloma
formation as shown by H&E staining.
Chronic HP Is Associated with Activated CD4+ and CD8+ T Cells
To identify the immune cells infiltrating the lungs during chronic HP, we
performed cell surface flow cytometry. Mice were exposed to SR for 25 weeks and the
lung cells were isolated and incubated with fluorochrome conjugated antibodies to CD45,
NK1.1, Gr-1, CD4, CD8, TCRE chain, CD69 and CD25.
As observed in the granulomatous HP, the results demonstrated a significant
decrease in the percentage of lung NK cells in the exposed mice compared to unexposed
mice (9.2% ±1.8 Vs. 3.1% ±0.8). We also found a signficant increase in the percentage of
neutrophils in SR exposed mice (14.7% ±2.6) compared to unexposed mice (6% ±1.4)
suggesting a pathogenic role at that stage of the disease. Furthermore, T cells represent
(28% ±4.5) of the total immune cells in the lungs compared to 17% ±3.19 in unexposed
mice. CD4+ T cells represent 18% ±3.4 of the total T cells in the lungs of mice following
chronic SR exposure while CD4+ T cells represent 9% ±2.7 of the total lung T cells of
controls. The activation marker CD69. SR exposed mice showed a signficant increase in
the percentage of CD4+/CD69+ T cells compared to unexposed mice (11% ±3 Vs. 2.7%
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Table 2-5.

Characterization of BAL cells during chronic HP.
T cells b
%(±SD)

1.25
(±1)

NK
cellsb
%(±SD)
28.21
(±13.1)

75.6
(±6.6)***

3.45
(+/-0.73)

Mice

Alveolitisa
(±SD)

PMN b
%(±SD)

Unexposed
C57BL/6J

0.65x106
(±0.37)

SR
Exposed
C57BL/6J

5.82x106
(±3.2)***

3.6
(±0.98)

CD4 T
cells b
%(±SD)
2.66
(±0.58)

CD8 T
cells b
%(±SD)
1.75
(±0.41)

8.4
(±3.39)**

4.6
(±2.1)**

2.52
(±1.1)

C57BL/6J mice (n=7-8/group) were exposed to SR (200Pg each) three times a week for
twenty five weeks then sacrificed 4 days following last exposure.
a
BAL was performed and recovered cells were counted using Trypan Blue dye
exclusion.
b
Cells isolated from the BAL fluid were incubated with antibodies to various cell surface
markers and analyzed by flow cytometry to determine cellular composition of the BALF.
PMNs were identified as CD11b+/Gr-1hi. NK cells were identified as NK1.1+ cells. T
cells were identified as TCRECD4 T cells as TCRECD4+, and CD8 T cells as
TCRE/CD8+. Results were expressed as means ±SD. Unpaired student’s t-test was used
to compare the mean of both groups. ( P<and
Psignificant
differencefrom the unexposed group.)

36

A

Figure 2-8.
exposure.

B

Peribronchiolar granuloma formation following 25 weeks of SR

Following 25 weeks of SR exposure, C57BL/6J mice were sacrificed and one lung lobe
was used for H&E. By staining lung sections from unexposed or SR exposed mice, we
showed granuloma formation in the exposed mice (Original magnification 63X). Panel A
represents lung section from unexposed mouse. Panel B represents lung section from SR
exposed mouse following 25 weeks of SR exposure.
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±1.7). Also, there was a signficant increase in CD4+/CD25+ T cells in SR exposed mice
compared to unexposed mice (3% ±0.8 Vs. 1.25% ±0.6). Although there was not a
significant diffenerce in the percentage of CD8+ T cells between unexposed and exposed
mice, we found a signficant increase in the percentage of activated CD8+ T cells
comapred to unexposed mice (3.3% ±1.2 Vs. 0.6% ±0.2) (Fig. 2-9). In conclusion, these
results demonstrated that chronic HP is associated with neutrophils, activated CD4+ and
CD8+ T cells in the lungs.
Chronic HP Is Associated with a Th17 Immune Response
Since the chronic phase of the disease is associated with fibrosis, it is important to
identify the type of immune response that contributes to disease severity. We examined
the T cell response following chronic exposure to SR to determine whether the influx of
activated T cells into the lungs of exposed mice was composed of Th1, Th2, or Th17
cells. We used semi-quantitative RT-PCR to measure the expression of T cell
differentiation factors and cytokines. Total RNA was isolated from the individual lung
lobes of mice exposed to SR for 25 weeks. Semi-quantitative RT-PCR was performed
using primers specific for Th1 cytokine IFNJ and Th1transcription factor T-bet, the Th2
cytokine IL-4, Th17 cytokine IL-17 and Th17 transcription factor RORJt. The results
demonstrated faint bands for IL-4 in 2/5 mice exposed to SR suggesting there was not a
switch to a Th2 response at this time point. There was an increase in IFNJ mRNA in the
exposed mice compared to unexposed mice; however, mRNA for the Th1 transcription
factor T-bet was not increased at this time point. Both IL-17 and the Th17 transcription
factor RORJt were increased suggesting that a Th17 response was maintained throughout
this stage of the disease (Fig. 2-10).
The upregulation in IL-17 and RORJt mRNA levels in the lung homogenates
suggested that Th17 cells had migrated into the lungs following SR exposure. In order to
measure the level of Th1 and Th17 cells in the lungs, we performed intracellular cytokine
staining. Mice were exposed to SR for 25 weeks and then lung cells were isolated
followed by ex vivo overnight stimulation with media or SR in presence of activated
adherent spleen cells. Flow cytometry was performed using antibodies against CD4,
TCRE chain (cell surface staining), IL-17 and IFNJ (intracellular staining).
Following ex vivo stimulation with SR, or media, there was a significant increase
in the percentage of Th17 cells compared to Th1 and IFNJ+/IL-17+ CD4+ T cells in the
lungs of SR exposed mice (Fig. 2-11). In conclusion, these data indicated that a
predominant Th17 immune response is associated with HP during its chronic stage
suggesting a pathogenic role for Th17 response during HP.
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Figure 2-9.
Cell surface staining showing the average percentage of different cell
populations in the lung interstium of unexposed and SR exposed mice following
25 weeks of SR exposure.
Lung cells were isolated from unexposed mice (n=7-8) and mice exposed to150Pg SR for
twenty five weeks. Cells were incubated with CD45, Gr-1, NK1.1, TCRE, CD4, CD8,
CD69, and CD25. Data was acquired on LSRII using FACS Diva Software.
Approximately 20,000 events were collected. Cells were gated as follows for NK cells
CD45+/NK1.1+, PMNs CD45+/CD11b+/Gr-1hi , T cells CD45/TCRE+, CD4 T cells
CD45+/TCRE+/CD4+, activated T cells as CD45+/TCRE+/CD4+ or CD8+/CD69+ or
CD25+. Results were expressed as means ±SD. Unpaired student’s t-test was used to
compare mean of both groups. (***P<0.001, significant differencecompared to
unexposed group.)
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Figure 2-10. mRNA expression of different cytokines and T cell transcription
factors from unexposed and SR exposed mice during chronic HP.
C57BL/6J mice (n=5) were exposed to150Pg SR for 25 weeks. Unexposed mice were
used as control. Total RNA was extracted from one lung lobe of individual mice and
reverse transcribed into cDNA for RT- PCR using primers specific for IL-4, IFNJ, IL-17,
RORJt, and T-bet. The housekeeping gene E-actin was used as an internal control.
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(A)

(B)

Figure 2-11. Intracellular cytokine staining showing percentage of Th17 and Th1
cells in the lungs following 25 weeks of SR exposure.
Lung cells were isolated from C57BL/6J unexposed mice (n=3) (used as a control) and
mice exposed (n=4) to 150Pg SR for 25 weeks. The cells were cocultured with C57BL/6J
IFNJ activated adherent spleen cells then stimulated ex vivo with media, or 10Pg SR at
37°C for overnight incubation. Cells were stained for CD45, CD4, TCRE, IL-17, and
IFNJ $ Representative Flow cytometry dot plot of IL-17 and IFNJ expression from
CD4+ T cells using intracellular cytokine staining showing increase in Th17 cells from
the lungs of WT mouse following media, SR or PMA/Ionomycin ex vivo stimulation. (B)
$verage percentage of Th1, Th17, and IFNJ+/IL-17+ CD4+ T cells in the lungs of SR
exposed mice. Results were expressed as means ±SD. One way ANOVA followed by
Tukey’s post ANOVA test was used to compare means of all groups (***P<0.0001).
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DISCUSSION
Acute HP: Neutrophilic Alveolitis and IL-17 Expression
The goal of this chapter was to determine the T cell response during HP. We
hypothesized that HP is associated with the Th17 cell response based on the correlation
between IL-17 upregulation in the lungs during HP and the neutrophil-rich environment
which is one of the hallmarks of Th17 response. Our initial studies demonstrated a
neutrophilic alveolitis during acute HP accompanied by an upregulation in mRNA
expression of CXCL2 and IL-17. This experiment was only showing the correlation
between expression of IL-17 and CXCL2 and neutrophil recruitment; however, the direct
effect of IL-17 on neutrophil recruitment during acute HP was not tested. Previous data in
our lab have showed that neutralization of IL-17 over a period of 3 weeks of SR exposure
decreased significantly the influx of neutrophils into the airways compared to control
mice. In summary, the data demonstrated the relation between IL-17 and CXCL2
expression and neutrophilic alveolitis during acute HP.
The previous data indicated that the initial response during acute HP is inclined
towards a Th17 cell response later on during adaptive phase of HP. However, further
experiments are required to prove this statement. Therefore, we measured the cytokines
associated with a Th17 immune response as well as cytokines required for Th17 cell
differentiation during acute HP. Using semi-quantitative RT-PCR, we identified an
upregulation in IL-6 while IL-21, IL-22, and IL-23 were detected but weakly expressed.
Since IL-6 is required for Th17 differentiation; therefore, the upregulation in IL-6 might
indicates a progression to Th17 cell development later on in the disease. The expression
of IL-23 at that stage of HP might be required for induction of IL-17 from other innate
cells e.g. JG T cells and NKT cells [160]. As mentioned in the introduction, IL-22 plays a
protective role at mucosal surfaces against bacterial infections through induction of
several mechanisms e.g. induction of antimicrobial peptides, enhancement of barrier
integrity. Although, it was reported that IL-22 plays a protective role against development
of fibrosis during HP, its role during acute HP was not addressed. In conclusion, these
results mean a probable Th17 response later on during adaptive stages of HP
(granulomatous and chronic HP).
Granulomatous HP and the Th17 Response
The detection of IL-6, IL-21, IL-22, and IL-23 during acute HP suggested that a
Th17- associated micro-environment developed after exposure to SR. Therefore, we
wanted to determine whether a Th17 immune response was present during the
granulomatous phase of the disease and so we examined mice that had been exposed to
SR for 3 weeks. The results demonstrated a lymphocytic alveolitis during granulomatous
HP rather than neutrophilic, where CD4+ T cells constituted a large percentage of T cells.
As mentioned earlier in the introduction, CD4+ T cells play a pathogenic role in HP.
Also, they are required for granuloma formation. Therefore, the presence of CD4+ T cells
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in the airways indicated their pathogenic role in the lungs. Since H&E staining showed
that granulomatous HP was associated with peribronchiolar granuloma, we measured the
phenotype of the T cells in the lung. As expected we found an increase in the percentage
of total T cells and the CD4+ T cells were activated as compared to unexposed mice
although the difference did not reach the level of statistical significance. By using only
3 mice per group, the statistical analysis was underpowered. The presence of activated
CD4+ T cells in the lungs suggested that the T cells encountered SR antigen presented by
APCs in the lungs. Also, it indicated that T cells are secreting their effector cytokines and
their interaction with APCs activates APCs to secret cytokines that contribute to lung
pathology. Also, there was no difference in the percentage of PMNs isolated from the
lung between unexposed and SR exposed mice. Since the mice were sacrificed 4 days
after last exposure, that might explain why we found low percentage of PMNs in the
lungs. The PMNs were recruited shortly after SR exposure then they died later on, while
the T cells remained activated because they encountered SR antigen in the lungs
presented by APCs. Finally, there was a signficant decrease in the percentage of NK cells
in the lungs of exposed mice compared to unexposed mice. NK cells could be
outnumbered by recruitment of other cell populations in the lungs. In conclusion, these
results suggested that during granulomatous HP, granuloma formation is associated with
activated CD4+ T cells.
Next, we wanted to examine the type of the CD4+ T cells in the lungs, whether
Th1, Th2, or Th17 developed during granulomatous HP. Using semi-quantitative
RT-PCR, we found an upregulation in the Th17 transcription factor, RORJt and Th17
signature cytokine, IL-17 suggesting that Th17 cells were present in the lungs and the
presence of IL-17 suggested that they are actively secreting IL-17. There was an increase
in the Th1 cytokine IFNJ but no increase in the transcription factor T-bet which indicated
that the increase in IFNJ was not from Th1 cells, but it could be from another type of cell.
Previous results from our lab showed that neutrophils are an important source of IFNJ
during HP [129]. Finally, we did not detect a significant upregulation of IL-4 in the
exposed mice as compared to the unexposed mice demonstrating that a Th2 response had
not developed. The absence of Th2 response during HP indicated that induction of
fibrosis during chronic stage is attributed to a different T cell response other than Th2
response; however, we still need to examine the T cell response during the chronic stage
to reach to this conclusion. Since the cytokine profile present in the lung suggested both
Th17 cells as well as Th1 cells (IFNJ production), we measured the level of SR antigen
specific Th1 and Th17 cells in the lungs using intracellular cytokine staining. We found
that SR antigen specific Th17 cells were the dominant effector T cells in the lungs after
3 weeks of SR exposure while SR antigen specific Th1 represented a small percentage
which is confirmed by PCR results. The presence of Th17 cell response in the lungs
associated with granuloma formation suggested to us that these cells could play a role in
the pathogenesis of HP during this stage. One study demonstrated the association of Th17
response with granuloma formation. Mouse infection with schistosome egg antigen with
Complete Freund’s Adjuvant (SEA/CFA) resulted in granuloma formation accompanied
by Th17 response. In conclusion, Th17 cells were associated with granuloma formation
during granulomatous HP suggesting their pathogenic role during HP.
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Chronic HP and Th17 Response
The next stage of our studies was to determine if the Th17 cell response was
associated with the chronic phase of the disease or if the response switched to a Th1 or
Th2 response. This is important since the chronic response is associated with fibrosis and
significant morbidity and mortality. We exposed mice to SR for 25 weeks and measured
several parameters of disease severity. The results demonstrated a neutrophilic alveolitis
with an increase in the number of T cells specifically CD4+ T cells, in exposed mice
compared to unexposed mice. These results were not surprising since neutrophils produce
mediators such as collagenases and gelatinases that cause tissue remodeling and fibrosis
which is the hallmark of chronic HP [113]. The increase in CD4+ T cells which reflected
to us their presence in the lung was also expected, since we found chronic HP was
associated also with granuloma as in the granulomatous phase using H&E staining. To
identify the cellular composition of the interstitial lung cell population during chronic
HP, we harvested the lungs after 25 week of chronic exposure protocol and performed
flow cytometry. We identified an increase in the percentage of lung neutrophils following
SR exposure compared to unexposed mice. In chronic HP patients, neutrophils express
gelatinases and collagenases which might contribute to fibrotic response during chronic
HP [113]. We also found that T cells represent the largest population in the lungs of
exposed mice especially activated CD4+ T cells and CD8+ T cells. The presence of
activated CD4+ T cells suggested that T ells encountered SR antigen in the lungs
presented by APCs and the activated CD4+ T cells are producing effector cytokines.
Although CD4+ T cells are the pathogenic T cells in HP, we had found activated CD8+
T cells during chronic HP. Previous studies in our lab demonstrated that CD8+ T cells do
not produce IL-17. These results suggested that during chronic HP, granuloma formation
is associated with activated CD4+, CD8+ T cells, and neutrophils.
To determine the type of activated CD4+ T cell whether Th1, Th2, or Th17; we
used semi-quantitative RT-PCR. Following 25 weeks of SR exposure, we found an
upregulation in the Th17 transcription factor (RORJt), IL-17 and IFNJ without change in
T-bet and IL-4 expression in SR exposed mice suggesting presence of both Th1 and
Th17 cells and the absence of Th2 cells at that stage. The absence of Th2 cells indicated
that the fibrosis process in that model is mediated by another type of T cells presumably
by Th17 cells. Since the cytokine profile present in the lung suggested that both
Th17 cells as well as Th1 cells (IFNJ production) were present, we measured the level of
SR antigen specific Th1 and Th17 cells in the lungs using intracellular cytokine staining.
The results demonstrated that SR antigen specific Th17 cells are still the
dominant effector T cells in the lungs after 25 weeks of SR exposure while SR antigen
specific Th1 represented a small percentage. Th17 cells could be contributing to the
fibrosis process during chronic HP through production of IL-17 as an effector cytokine.
IL-17 consequently induces neutrophil recruitment into the lungs which is already
observed during chronic HP. Finally, neutrophils might play a role in fibrosis through
secretion of gelatinases and collagenases that cause tissue remodeling and eventually
fibrosis [113]. In conclusion, Th17 cells might play an indirect role in fibrotic response
possibly through neutrophil recruitment during chronic HP.
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IFNJ/IL-17+ CD4+ T cells were only observed following PMA/Ionomycin and
they were absent following ex vivo media and SR stimulation. Th1/Th17 cells can be
generated from Th17 cells following IL-12/IFNJ stimulation [171], hence,
PMA/Ionomycin might be stimulating IL-12 and IFNJ production that can switch Th17
response to Th1/Th17 response. The origin of the double producers is not clear but there
have been several studies addressing this issue. Hirota et al. demonstrated that the double
producers originally derived from Th17 cell [172]. Since these cells were enriched in
target organs of several autoimmune diseases, it was suggested that these cells were
pathogenic; whether these cells were pathogenic or protective it was not shown clearly in
the literature [173].
Th17 Response and HP: A Correlation Not a Cause and Effect Study
Our results from this chapter demonstrated a correlation between disease severity
and Th17 response. The role of Th17 cells in HP still remains to be answered. Simonian
et al. demonstrated that reconstitution of TCRE/G DKO mice (mice lacking CD4+, CD8+,
and JG T cells) with splenic naïve CD4+ T cells followed by SR exposure for 4 weeks
resulted in lung inflammation and increase in lung collagen content as a measurement of
fibrosis. This coincided with an increase in IL-17 expression in the lung homogenates
compared to those mice exposed to PBS. These data demonstrated the importance of
CD4+ T cells as inducers of lung inflammation and fibrosis during HP in a direct or
indirect way. Furthermore, repeated exposure of WT mice to SR for 4 weeks increases
the frequency of Th17 in the lungs [62]. To identify the role of IL-17 in HP Simonian et
al. and Joshi et al used IL-17RKO and IL-17KO mice and exposed them to SR [62, 174].
Both studies demonstrated a significant reduction in lung inflammation [62, 174] and
collagen deposition in IL-17R knockout exposed mice compared to WT exposed mice
[62]. Even though IL-17 is one of the signature cytokines of Th17, it is still produced by
other immune cells [157-159]. Adoptive transfer experiment could be performed to
investigate the direct role of Th17 during HP. In this experiment, Th17 cells from SR
exposed mice will be adoptively transfered into TCRE/G DKO mice followed by SR
exposure then lung inflammation and collagen content will be tested. In summary, the
authors concluded from their data that Th17 plays a pathogenic role of Th17 during HP
[62]; yet, how these cells cause lung fibrosis remains to be an open question.
Our results demonstrated an increase in IL-22 in the lungs following SR exposure.
The role of IL-22 in lung fibrosis was previously addressed during HP by Simonian et al.
[175]. In a HP mouse model caused by B. subtilis, IL-22 is produced mainly by a subset
of JGT cells. IL-22 expression from JG T cells requires stimulation of the Aryl
hydrocarbon receptor (AhR) by environmental toxins [176]. In B. subtilis mouse HP
model, AhR mutant mice (AhRd/d) are characterized by reduced IL-22 expression by JGT
cells along with increase in collagen deposition [175]. To confirm these data,
recombinant IL-22 was injected into (AhRd/d) mice and TCRGKO mice exposed to
B. subtilis causing reduction in collagen content as well as reduced lung CD4+ T cell
recruitment and lung inflammation. In the same line of evidence, neutralization of IL-22
in WT mice exposed to B. subtilis for 4 weeks resulted in an increase in the amount of
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collagen and the number of CD4+ T cells in the lungs compared to mice treated with
isotype antibody [175]. Taken together, these data suggest that IL-22 plays a protective
role in the B. subtilis induced HP model. In Farmer’s Lung disease model, the frequency
of CD4+ T cells expressing IL-22 in lungs is low [62] and IL-22 produced by JG T cells
during B. subtilis induced HP is protective [175]. Although both models are induced by
different agents, a correlation can be drawn from these two studies. The low expression
of IL-22 in Th17 cells during HP might be contributing to the disease severity. In
conclusion, we hypothesized that HP is a Th1/Th17 mediated disease, yet the
contribution of each subset to disease severity is still enigmatic. Several experimental
disease models showed the coexistence of both Th1 and Th17 cells during the disease
progression. In the T. cruzi mouse infection model, a Th1 response develops upon antigen
challenge as well as a strong Th17 response [170]. In experimental autoimmune uveitis as
a model for human uveitis, either Th1 or Th17 cells can cause the disease [177].
Furthermore, in experimental autoimmune encephalomyelitis (EAE), both Th1 and Th17
cells infiltrate the CNS [178] and antigen specific Th1 or Th17 cells generated in vitro
adoptively transfer the disease into naïve mice [179]. Thus, all the previous studies
showed the coexistence of Th1 and Th17 in different diseases. The cooperation between
both types of T cells was demonstrated in EAE model when Th1cells collaborate with
Th17 cells by facilitating the entry of Th17 into CNS [180]. In summary, our results from
this chapter demonstrated a predominant Th17 response with low percentage of Th1 cells
during granulomatous and chronic HP.
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CHAPTER 3.

T-BET IN HP*

The results from chapter 2 indicated that both granulomatous and chronic HP are
associated with a predominant Th17 response. However, HP was considered as
Th1-mediated disease, since IFNJwas required for granuloma formation during HP. In
order to clarify the role of IFNJ in the disease, we examined the regulation more closely.
In this chapter, we will identify the cytokines required for IFNJ production from
neutrophils, determine role of T-bet in the regulation of Th17 development and disease
severity. The results demonstrated that combination of IL-12/ IL-18 or IL-15/IL-18 were
required for induction of IFNJ from neutrophils and T-bet inhibits Th17 response and
controls disease severity during HP.
INTRODUCTION
T-bet (T-box expressed in T-cells) is the master transcription factor required for
Th1 differentiation >@. Although the name suggests that it is expressed by T cells only,
other immune cells such as dendritic cells [9], NK, and NKT cells [10] can express it as
well. During Th1 polarization, the expression of T-bet in naïve T cells is induced by the
synergistic effect of TCR stimulation and IFNJSTAT1 signaling. Induction of T-bet
induces expression of the IL-12RE2 subunit on the cell surface increasing responsiveness
of the cell to IL-12. With additional IL-12 stimulation more T-bet is induced resulting in
amplification of the reaction. T-bet also induces an array of genes such as IFNJ, CCL4,
CCL3 and CXCR3 (chemokine receptor for CCL3 and CCL4). Since these chemokines
are important for Th1 cell migration T-bet indirectly contributes to Th1 cell recruitment
to sites of inflammation [181]. Although, IFNJ is the prototypic cytokine produced by
Th1 cells, other immune cells, such as CD8+ T cells, NK cells, NKT cells, antigen
presenting cells and neutrophils [182-184] can express it as well. Neutrophils are
considered as an important source of IFNJduring HP [129]; however, it is not known
how IFNJ expression is induced in neutrophils and whether T-bet is expressed by
neutrophils is still unclear. Several cytokines have been reported to stimulate IFNJ from
neutrophils including IL-12 alone or in combination with IL-2, IL-15, IL-18, or LPS. The
combination of IL-12 with IL-15 was the most efficient at inducing IFNJ production from
human neutrophils [183]. In a different study neutrophils isolated from human uterine
endometrium tissue were able to produce IFNJ upon stimulation with a combination of
TNFD and IL-12 [182]. Finally, peritoneal murine neutrophils produced IFNJ following
stimulation with LPS [185]. In this chapter we will identify the cytokines that induce
IFNJ production from neutrophils isolated from SR exposed mice.
Regulation of IFNJ production and Th1 differentiation is not the lone function of
T-bet. T-bet can also inhibit Th2 differentiation by binding to GATA-3 (a Th2
transcription factor) and hence sequester GATA-3 from binding to IL-5 and IL-13
*(Adapted with permission from Abdelsamed, H.A., et al., T-bet controls severity of
hypersensitivity pneumonitis. J Inflamm (Lond), 2011. 8(1): p. 15 [186].)
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promoters. T-bet also binds to Runx-3 transcription factor and both bind to the IL-4
silencer to inhibit IL-4 expression [181]. Recently, Lazarevic et al. showed that T-bet
binds to Runx-1 transcription factor inhibiting the expression of Th17 specific
transcription factor RORJt expression and hence RORJt target genes expression e.g.
IL-17a, IL-17f, and IL-23r [187] (Fig. 3-1). Therefore, the expression of T-bet during the
development of HP may not only influence the development of a Th1 response but also a
Th2 and Th17 response. In this chapter we will identify whether a deficiency in T-bet
results in the development of a Th2 or Th17 response in HP and how that affects
granuloma development and fibrosis.
The role of T-bet in different infectious and organ specific autoimmune disease
models has been addressed in several studies [188-196]. Since Th1 cells are important for
clearance of intracellular pathogens and T-bet is required for Th1 differentiation, deletion
of T-bet in mice renders them susceptible to a wide range of intracellular pathogens e.g.
Mycobacterium tuberculosis [188], Leishmania major [195], Staphylococcus aureus
[189], and Salmonella typhimurium [190]. However, T-bet also may play a role in
autoimmune diseases. T-bet KO mice are resistant to the development of several
autoimmune diseases e.g. experimental autoimmune encephalitis (EAE) [191, 196],
arthritis [192], and type I diabetes [193, 194]. Furthermore, T-bet KO mice infected with
S. mansoni showed increase in disease severity accompanied by increase in Th17
cytokines [169]. Additionally, in T. cruzi mouse infection model there was an increase in
the percentage of Th17 cells from the spleens of T-bet KO mice [170]. Several studies
demonstrated the role of T-bet in fibrosis. T-bet KO mice treated with bleomycin showed
an increase in lung and skin collagen content compared to WT mice [64, 65]. The goals
of the studies are to determine the cytokines required for IFNJ expression from
neutrophils during HP and the effect of T-bet on disease severity and Th17 response
during HP.
MATERIALS AND METHODS
Animals
Female C57BL/6J WT and T-bet KO mice were purchased from Jackson
Laboratories (Bar Harbor, ME) and used in experiments between 6-10 weeks of age.
Sterile micro-isolator cages with sterile food and water ad libitum were used for animal
housing. All the protocols were approved by the Institutional Animal Care and Use
Committee (IACUC), the University of Tennessee Health Science Center. All animals
were maintained by the Division of Comparative Medicine at the University of Tennessee
Health Science Center according to the guidelines of the animal welfare act.
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Figure 3-1.
cells.

Role of T-bet in differentiation of different subsets CD4+ helper T

In Th1cells, T-bet induces IFNJ, CXCR3, CCL3, CCL4, and IL-12RE2 gene expression.
T-bet inhibits Th2 differentiation by sequestering GATA-3 from binding to its specific
promoters. T-bet inhibits differentiation of Th17 through binding to transcription factor
Runx-1 inhibiting expression of RORJt. (Adapted with permission Lazarevic, V. and
L.H. Glimcher, T-bet in disease. Nat Immunol, 2011. 12(7): p. 597-606 [181].)
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Spleen Cell Isolation and Stimulation
Single cell suspension from spleen was prepared by digesting spleen tissue in a
Stomacher® 80 tissue processor. RBCs were lysed and the cell suspension was washed
with sterile PBS. In a 96-well plate, 5x105 cells/well were stimulated with media alone,
5Pg lyophilized SR, 5Pg lyophilized SR in the presence of anti-IL12p40 (10Pg/ml),
anti-IL-15 (10Pg/ml), anti-IL18 (10Pg/ml) individually or in combination. After 24
hours, culture supernatants were collected to measure IFNJ concentration using ELISA.
Neutrophil Cell Sorting and Stimulation
A cell sorter (BD FACSAria) was used to sort lung neutrophils from C57BL/6J
mice. Mice were exposed to 225Pg SR one time; and sacrificed 18 hours post-exposure.
A single cell suspension of lung cells was prepared and the cells incubated with
fluorchrome labeled antibodies to the following cell surface markers: CD45, CD11b,
Gr-1, and NK1.1. Neutrophils were sorted as (CD45+/CD11b+/Gr-1hi /NK1.1-) and plated
at 7.5x105cells/well in a 96-well plate. The cells were stimulated with IL-12 (10ng/ml),
IL-18 (20ng/ml), and or IL-23 (20ng/ml) individually or in combination. After overnight
incubation, the culture supernatants were collected to measure IFNJ concentration by
ELISA.
RNA Extraction and Real-Time PCR
RNA Extraction
Total RNA was extracted from one lung lobe from individual mice using Trizol
(Invitrogen, Carlsbad, CA). Contaminating genomic DNA was removed by treating the
RNA samples with DNase (Turbo DNA free, Ambion, Austin, TX). RNA concentration
was determined by measuring the absorbance of UV light at 260nm, and 280nm using
Ultrospec 2000 spectrophotometer (Pharmacia Biotech, Piscataway, NJ). The
concentration of RNA (μg/ml) was calculated by multiplying the absorbance (A260), the
dilution factor and 40μg/ml.
To determine the quality of the RNA 1-2Pgs were loaded on a 4% agarose gel and
analyzed for the presence of 18S and 28S ribosomal RNA subunits as indicator of intact
RNA.
Real-Time PCR
One Pg of RNA was reverse transcribed into cDNA using Transcriptor First
Strand cDNA synthesis kit (Roche Applied Science, Indianapolis, IN). Each PCR cycle
was run using a LC480 light cycler with and activation step at 95oC for 5 minutes,
denaturation at 94°C for 10 sec, annealing for 30 seconds at 60oC and extension at 72oC
for 10 seconds. The reaction was amplified for 50 cycles. The housekeeping gene HPRT
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was used to normalize mRNA levels and ¨¨ct method was used to calculate fold increase
over the unexposed controls. All primers and probes were chosen from online software
Universal Probe Library available at <http://www.roche applied
science.com/sis/rtpcr/upl/index.jsp>.
Histology
The perfused left lung lobe was harvested and fixed overnight in neutral buffered
formalin at 4oC. The lung tissue was embedded in paraffin and sectioned into 8 Pm
sections and stained with Hematoxylin and Eosin (H&E) by the Department of
Pathology, UTHSC.
Measurement of Lung Collagen Content
The Sircol™ Collagen Assay (Biocolor Ltd., UK) was performed to measure
collagen in the lungs of individual mice per manufacturer’s instructions. The right lung
lobe was homogenized in 0.5M acetic acid containing protease inhibitors and incubated
for 24 hours at 4°C with shaking to extract acid soluble collagen. One ml of the
homogenate was centrifuged at 15000xg for 1 hour and the supernatant removed and
clarified by passage through a 0.22Pm syringe filter. The standard curve was prepared
from the collagen stock solution (1mg/ml) using 2-fold serial dilutions in deionized water
The samples and standards were added to 1ml of sircoll dye followed by incubation at
room temperature for 30 minutes with shaking. Following centrifugation at 10,000xg for
10 minutes, the unbound dye was aspirated and 1 ml of alkali solution was added. Two
hundred Pl was transferred to a 96-well plate and absorbance at 550nm recorded. The
concentration of the unknowns was calculated from the standard curve.
Statistical Analysis
Values were expressed as mean ±S.D. For comparison of means between two
populations of unpaired data, unpaired student’s t-test was used. For comparison between
more than two groups, One-way ANOVA followed by Tukey’s post ANOVA test was
used. GraphPad Prism was used to perform all tests. Differences were considered
significant at P <0.05.
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RESULTS
Regulation of IFNJ during HP
Neutralization of IL-12p40 Inhibits IFNJ Production from S. rectivirgula Stimulated
Spleen Cells
Previous studies in our lab showed that neutrophils are the main source of
IFNJfollowing SR exposure [129]; however, it was unknown whether SR could induce
IFNJdirectly or indirectly through induction of cytokines that stimulate IFNJproduction
e.g. IL-12, IL-15, IL-18, and IL-23. Spleen cells were isolated from C57BL/6J mice and
then stimulated with SR alone or in the presence of anti-IL-12p40 antibody (will
neutralize both IL-12 and IL-23), anti-IL-15 antibody, and anti-IL-18 antibody
individually or in combination. Twenty four hours later, culture supernatants were
collected for measurement of IFNJ using ELISA. As shown in Fig. 3-2, SR stimulated
IFNJ production from spleen cells and this stimulation was unaffected by the addition of
antibody to IL-15 or IL-18 suggesting they do not play a role in SR stimulation of IFNJ.
However, SR stimulation of IFNJ was inhibited by neutralization of IL-12p40 alone or in
combination with the other antibodies. This data suggested that SR mediates induction of
IFNJ from spleen cells via IL-12 and/or IL-23 since both cytokines share the IL-12p40
chain.
IL-12/IL-18 Combination but not IL-23 Combination with IL-12 or IL-18 Induces IFNJ
from Neutrophils
Previous studies in the lab had suggested that IL-18 in combination with IL-15 or
IL-12 was able to stimulate IFNJ production from neutrophils. However, the data in the
previous section suggested that either IL-12 or IL-23 stimulated by SR could induce
IFNJ. Therefore, we wanted to determine whether IL-23 alone or in combination with
other cytokines could stimulate IFNJ production. We sorted neutrophils from the lungs of
mice exposed to SR one time and stimulated them with IL-12, IL-18, and IL-23
individually or in combination and measured IFNJ production by ELISA. Only the
combination of IL-12/IL-18 induced IFNJ from neutrophils, while IL-23 individually or
in combination with IL-12 or IL-18 did not (Fig. 3-3). These data suggested that neither
IL-23 alone nor combination with other cytokines can stimulate IFNJ production from
neutrophils. Only IL-12 in combination with IL-18 can stimulate IFNJ from neutrophils.
Role of IL-18 and T-bet in IFNJ Production
Since our previous studies demonstrated that IL-18 in combination with either
IL-12 or IL-15 stimulated IFNJfrom sorted neutrophils significantly more than any other
combination, it suggests that IL-18 is critical for neutrophil IFNJ production.
Additionally, IL-18 stimulates IFNJ through T-bet [197]. We hypothesized that SR uses
the transcription factor T-bet for IFNJ production. To test this hypothesis, spleen cells
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Figure 3-2.

SR induces IFNJ from spleen cells indirectly through cytokines.

Spleen cells isolated form C57BL/6J mice (n=4) were stimulated for 24 hours with SR
(5Pg) alone or in the presence of anti-IL-12p40 antibody (10Pg/ml), anti-IL-15 antibody
(10Pg/ml), anti-IL-18 anitbody (10Pg/ml) individually or in combination. Culture
supernatants were collected and IFNJ was measured by ELISA. Data were expressed as
means ± SD. All cytokine combinations compared to each other using one way ANOVA
followed by Tukey’s post ANOVA test. (*P<0.05 and **P<0.01 significant difference
from spleen cells stimulated with SR.)
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Figure 3-3. Neither IL-12 nor IL-23 alone stimulates IFNȖ production by
neutrophils.
Neutrophils (CD45+/CD11b+/Ly6G+/NK1.1-) were sorted from the lungs of mice exposed
one time with 225Pg SR then sacrificed18 hours post SR exposure. The neutrophils were
stimulated with IL-12, IL-18, IL-23 individually or in combinations for 18 hours
approximately. Culture supernatants were collected and IFNJ was measured using
ELISA. Data were expressed as means ± SD. Using unpaired student’s t-test, means of
control media were compared to IL-12/IL-18 induction. (***P<0.0001 significant
difference from media control group.)
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from WT or T-bet KO mice were stimulated with SR. Culture supernatants were
collected after 24 hour of stimulation and IFNJ was measured using ELISA. The results
demonstrated that following SR stimulation WT spleen cells produce a significant
amount of IFNJ compared to T-bet KO spleen cells (Fig. 3-4). These results suggested
that SR induced IFNJfrom spleen cell in a T-bet dependent manner.
Role of T-bet in HP
T-bet Inhibits Development of the Th17 Response during HP
The previous section demonstrated the importance of T-bet in regulation of
IFNJduring acute HP. Regulation of IFNJ is not the only function of T-bet. It is also
involved in Th1cell recruitment through upregulation of the chemokine receptor CXCR3
and chemokines CCL3 and CCL4 [198, 199]. Additionally, T-bet is known to inhibit
Th17 differentiation [187] and the predominant response during granulomatous and
chronic HP was the Th17 response. Therefore, we examined the effect of T-bet on
theTh17 response and disease severity during HP. Following three weeks of SR exposure,
we found an increase in IL-17 mRNA expression in the lungs of T-bet KO mice
compared to WT exposed mice. Also, there was a non-significant reduction in IFNJ
mRNA expression (Fig. 3-5).
Since we found an increase in IL-17 mRNA levels in T-bet KO mice, we
measured IL-17 in BALF from T-bet KO and WT exposed mice using ELISA. Previous
data in our lab showed an increase in IL-17 protein expression from BALF of T-bet KO
mice compared to WT mice following three weeks of SR exposure. The upregulation of
IL-17 mRNA and protein expression led us to determine the frequency of lung Th17 cells
from T-bet KO and WT exposed mice. Previous studies in our lab showed a significant
increase in the percentage of Th17 cells from the lungs of T-bet KO mice compared to
WT exposed mice following ex vivo SR stimulation. In conclusion, these results
demonstrated the inhibitory effect of T-bet on Th17 development during granulomatous
HP.
Tbet Controls Severity of HP
As demonstrated in chapter 2, Th17 cells were associated with granuloma
formation as well as the chronic phase of disease. In this chapter we showed an increase
in the percentage of Th17 cells from T-bet KO exposed to SR. We hypothesized that the
increase in Th17 cells in the T-bet KO mice would result in an increase in disease
severity. WT and T-bet KO mice were exposed to SR for 3 weeks and granuloma
formation in the lungs measured. The results demonstrated an increase in granuloma
formation in T-bet KO mice exposed to SR compared to WT mice exposed to SR
(Fig. 3-6).
The increase in granuloma formation in T-bet KO mice exposed to SR suggested
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Figure 3-4. IFNJ production from spleen is T-bet dependent following SR
stimulation.
Spleen cells were isolated from WT and T-bet KO mice then stimulated with 10Pg SR.
Culture supernatant was collected following 24 hours incubation period. IFNJprotein
levels were measured using ELISA
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A

B

Figure 3-5. Real-time PCR showing expression levels of IL-17 and IFNJin lungs
of WT and T-bet KO mice following 3 weeks of SR exposure.
Real-time PCR showing expression levels of IL-17 and IFNJin lungs of WT and T-bet
KO exposed mice. WT and T-bet KO mice were exposed to 150Pg SR for three weeks.
RNA was extracted from one lung lobe then reverse transcribed to cDNA. Real-time PCR
was performed using primers specific to IL-17 (Panel A) and IFNJ (Panel B). Results
were normalized to the house keeping gene HPRT and expressed as fold induction over
unexposed mice. Results were expressed as mean ±SD. Using unpaired student’s t-test,
means of both groups were compared showing a non-significant difference.
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B

A
WT
Figure 3-6.

T-bet KO

Granuloma formation in WT and T-bet KO mice.

H&E stained lung section from WT and T-bet KO mice exposed to 150Pg SR for three
weeks. (Original magnification 63X). Panel A represents lung section from WT SR
exposed mouse. Panel B represents lung section from T-bet KO SR exposed mouse.
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to us there will be an increase in disease severity upon subsequent exposures. Using the
Sircoll assay we measured collagen content as a measure of fibrosis in the lungs of mice
exposed to SR for six weeks. The results demonstrated a significant increase in lung
collagen content from T-bet KO exposed mice compared to WT exposed mice (Fig. 3-7).
In conclusion, these results suggested that T-bet plays a protective role during HP,
possibly by limiting Th17 cell generation.
DISCUSSION
The pathogenic role of IFNJ during HP was addressed by Gudmundsson and
Hunninghake [128]. They found that IFNJ KO (GKO) mice did not develop granulomas
following SR exposure for 3 weeks compared to WT exposed mice that developed
granulomas. Furthermore, the replacement of IFNJ in GKO mice via intraperitoneal
injections of IFNJ restores back granuloma formation in GKO SR exposed mice [128].
Those early studies suggested that the source of IFNJ was Th1 cells however, that was
never proven. Previous studies in our lab did not find a large percentage of Th1 cells
during HP, rather these studies demonstrated that innate immune cell IFNJ production
was sufficient for disease. Additionally, one of the innate immune cells contributing to
IFNJ production was the neutrophil [129]. However, elucidation of the cytokines required
for IFNJ expression from neutrophils and/or during HP was not addressed. Several
cytokines can stimulate IFNJ from different immune cells and they may function in a
T-bet dependent or independent manner. IL-2, IL-12, IL-15, IL-18, TNFD as well as LPS

Figure 3-7.

Increased collagen content in the lungs of T-bet KO mice during HP.

C57BL/6J or T-bet KO mice (5/group) were exposed to 150ug SR or saline for six weeks.
The right lung lobe was removed from mice and collagen content was determined using
sircoll assay. The results are expressed as amount of collagen/right lobe and represent the
mean ± SD. Using unpaired student t-test, mean of WT exposed group was compared to
mean of T-bet KO exposed group. (*P<0.05.)
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have all been demonstrated to stimulate IFNJ from macrophages and neutrophils [182,
183, 200]. Our results found that neutrophils sorted from SR exposed mice (single
exposure) produced IFNJ in response to IL-18 in combination with IL-12 or IL-15, but
not to any cytokine alone. It has been reported that alveolar macrophages isolated from
HP patients produce IL-12 and IL-18 spontaneously without ex vivo stimulation. [114].
Therefore, these cytokines produced by AMs might be crucial for production of IFNJ
from neutrophils. In conclusion, the data demonstrated to us the importance of IL-12,
IL-15, and IL-18 in production of IFNJ from neutrophils during HP.
IL-18 can stimulate IFNJ expression through T-bet [197], and so we asked
whether SR induction of IFNJ was also through T-bet Spleen cells isolated from a T-bet
KO mouse did not produce IFNJ following SR stimulation compared to WT spleen cells.
These results suggested that neutrophil IFNJ production may be dependent on T-bet;
however, we were not successful in our attempts to demonstrate T-bet in neutrophils
using intracellular staining. One problem with the experiment was not having a strong
positive control such as a type of immune cells that express high levels of T-bet. A
separate experiment would be to sort neutrophils from T-bet KO SR exposed mice to
check the expression of IFNJ in the absence of T-bet. In conclusion, the results from
these studies revealed the importance of T-bet and combination of IL-18/IL-15 or
IL-18/IL-12 in IFNJ regulation during acute HP.
Our studies in chapter 2 found that HP was associated with a Th17 response rather
than a Th1 or Th2 response. However, there was a small percentage of SR antigen
specific Th1 cells in the lungs of exposed mice. Previous studies from our lab
demonstrated that during HP, IFNJ produced by Th1 cells is not necessary for granuloma
formation this raises the question “what is the role of Th1 cells in the disease severity and
regulation of Th17 response during HP?” To answer this question we used T-bet KO
mice which lack the ability to mount Th1 cell responses. We exposed WT and T-bet KO
mice for three and six weeks and examined the Th17 response, granuloma formation, and
fibrosis in the lungs. We found an upregulation in IL-17 mRNA and protein expression
following 3 weeks of SR exposure compared to WT exposed mice. In addition, there was
an increase in the percentage of Th17 cells in the lungs following SR exposure compared
to WT exposed mice. These results suggested a regulatory effect of T-bet on Th17 cell
development and expression IL-17 expression. Several disease models demonstrated the
regulatory effect of T-bet on Th17 effector cytokines. In the S. mansoni mouse infection
model, T-bet KO mice showed an increase in Th17 cytokines compared to WT infected
mice [169]. In another parasitic mouse infection model, T-bet KO mice develop a strong
Th17 response in the spleens compared to WT mice following T. cruzi infection. Also
there was an increase in the number of neutrophils in the blood [170].
The increase in Th17 cells during the granulomatous phase of the Tbet KO mice
suggested to us that the disease was more severe and therefore we examined granuloma
formation and fibrosis in the WT and T-bet KO mice. As expected following 3 weeks of
SR exposure we found an increase in granuloma formation in T-bet KO mice compared
to WT mice although we have not quantified it by measuring the area of the granulomas
between the WT and Tbet KO groups. Since the morbidity of the disease is due to
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fibrosis, we measured the collagen content in the lungs of WT and T-bet KO mice and
found an increase in collagen in the T-bet KO mice following 6 weeks of SR exposure.
Taken together, the shift to stronger Th17 response in T-bet KO exposed mice correlated
with increase in disease severity. These data suggested two roles for T-bet during HP.
First, it suggested the protective role of T-bet. Second, the inhibitory effect of T-bet on
Th17 development; however the exact mechanism by which T-bet inhibits Th17
development was not clear until recently. Lazarevic et al. showed that T-bet binds to
Runx-1 transcription factor inhibiting expression of Th17 specific transcription factor
(RORJt) and hence its target genes IL-17a, IL-17f, and IL-23r [187].
The data from these studies demonstrated the role of T-bet in disease severity and
its effect on Th17 development during HP. Our results do not identify whether T-bet
expression by an innate or adaptive immune cell is responsible for the inhibition of Th17
development. The direct experiment to fulfill this aim would require an adoptive transfer
experiment. WT or T-bet KO CD4+ T cells from naïve mice will be injected into RAG-2
KO mice. Both groups of mice will be exposed to SR for three weeks (3 days/week). We
might expect two scenarios. The first scenario, if both groups developed an equal
percentage of Th17 cells in the lungs, the T-bet expressed by T cells does not play a role
in Th17 development during HP. The second scenario, if the frequency of Th17 cells is
more in the group that received T-bet KO T cells than the one received WT CD4+ T cells
therefore, T-bet regulates development of Th17 in T cell intrinsic manner. In T. cruzi
mouse infection model, T-bet regulates Th17 development in T cell intrinsic manner. The
authors showed the adoptive transfer of naïve T-bet KO CD4+ T cells into RAG-2 KO
enhance expression of IL-17 from CD4+ T cells more than WT transfer to RAG-2 KO
mice [170].
The role of T-bet in different infectious and organ specific autoimmune disease
models has been addressed in several studies [188-196] . In the S. mansoni mouse
infection model, T-bet KO mice showed an increase in disease severity accompanied by
upregulation in Th17 cytokines compared to WT infected mice [169]. T-bet KO mice
infected with schistosome egg antigen in CFA (SEA/CFA) developed larger liver
granulomas infiltrated with neutrophils compared to WT infected mice [169].
Furthermore, there was an increase in Th17 effector cytokines (IL-17, IL-21, and IL-22)
as well as neutrophil chemokines CXCL1 and CXCL2 [169]. In another parasitic mouse
infection model, T-bet KO mice develop a strong Th17 response in the spleens compared
to WT mice following T. cruzi infection. Also there was an increase in the number of
neutrophils in the blood [170]. T-bet does not regulate only granuloma formation and
Th17 response in disease, but also it can regulate fibrosis. For example, in
bleomycin-induced lung injury mouse model, T-bet KO mice were characterized by an
increase in lung collagen content as a marker for fibrosis compared to WT mice [64].
Since T-bet KO mice exposed to SR were characterized by an increase in Th17
cells as well as an increase in disease severity, the next experiment is to figure out if
Th17 cells are required for granuloma formation. To address this question, previous
studies in our lab used IL-6 KO mice. IL-6 is one of the cytokines required for Th17
development [16]. When the lung cells from these mice were culture in vitro with
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PMA/Ionomycin and intracellular cytokine staining was used to phenotype these cells, it
was determined that the absence of IL-6 resulted in a significant decrease in Th17
percentage and increase in Th1 percentage in the lungs of IL-6 KO exposed mice
compared to WT exposed mice. However, there was no difference in granuloma
formation between WT and IL-6 KO exposed mice as examined by H&E staining. These
data indicated that Th17 were not required for granuloma formation and Th1 response
was sufficient for granuloma formation indicating that both Th1 and Th17 may coexist
during HP. Several experimental disease models showed the coexistence of both Th1 and
Th17 cells during the disease progression. In EAE, both Th1 and Th17 are infiltrating the
CNS [178] and antigen specific Th1 or Th17 generated in vitro adoptively transfer the
disease into naïve mice [179]. In T. cruzi mouse infection model, normal Th1 response
developed upon antigen challenging along with strong Th17 response [170]. In
experimental autoimmune uveitis as a model for human uveitis, either Th1 or Th17 can
cause the disease [177]. The cooperation between both types of T cells was demonstrated
in EAE model where Th1cells collaborate with Th17 cells by facilitating the entry of
Th17 into CNS [180]. In the same line of evidence, during HP either Th1 or Th17 may
cause disease severity and the tipping balance point between both populations might
regulate the disease severity.
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CHAPTER 4. EFFECT OF TLR2 AND 9 IN APCS ON TH17 CELL
POLARIZATION AND EFFECTOR FUNCTION
The results from chapters 2 and 3 demonstrated that the Th17 response was
predominant over the Th1 response during HP and may contribute to disease severity.
Consequently, we were looking for other factors that might control the Th17 response in
our model. Activation of antigen specific T cells depends on interactions with innate
immune cells which in turn are activated by the presence of a microbe. The innate
immune cells recognize microbes using Toll like receptors (TLRs) expressed on the cell
surface and in the cytoplasm. Previous results in our lab showed that the frequency of
Th17 cells was significantly less in the lungs of TLR 2/9 double Knockout (DKO) mice
compared to WT mice during HP. The aim of this chapter is to determine whether TLRs
2 and 9 expressed by antigen presenting cells contributes to the Th1 or Th17 response
during HP.
INTRODUCTION
Antigen Processing, Presentation, and Recognition Processes
As introduced in chapter one, naïve T cell differentiation takes place in the lymph
nodes where DCs are presenting specific antigen to naïve T cells. DCs provide naïve T
cells with three signals. The culmination of the three signals ultimately leads to T cell
differentiation into Th1, Th2, or Th17. The process of T cell differentiation requires the
combination of sequential processes that take place at different anatomical sites. The first
process occurs at the site of infection where immature DCs, that have a high phagocytic
activity, phagocytose the microbial pathogen. Consequently, DCs undergo a maturation
program allowing them to migrate to the regional lymph nodes and present the microbial
antigen to naïve T cells. Immature DCs express a wide range of phagocytic receptors
involving lectins and scavenger receptors with a very high phagocytic activity; however,
once they get exposed to an inflammatory signal e.g. TLR ligand or inflammatory
cytokine, they undergo a program of maturation. Mature DCs are mainly functional as
antigen presenting cells. There are several events that occur during the DC maturation
process. For example, downregulation of their phagocytic capacity, translocation of
MHCII from the lysosomal compartment to plasma membrane increasing the expression
of MHCII on the cell surface, upregulation in MHCI and costimulatory molecules
expression as well [5]. All of these characteristics endow mature DCs with the capacity to
become the most efficient APCs for priming naïve T cells at the lymph nodes while
macrophages are inherently oriented towards activation of effector T cells already present
at the site of inflammation. Also, the macrophages lysomal compartment is more adapted
toward complete clearance of the microorganism [201].
Following phagocytosis, antigen presentation and antigen recognition processes
take place. The recognition of antigens by T cells is a crucial process both in terms of
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initiating the adaptive immune response at the lymph nodes as well as maintaining the
effector phase of the immune response at the site of infection. Antigen recognition by
T cells as mentioned earlier is preceded by two subsequent processes; antigen processing
and presentation. Antigen processing begins with a form of internalization in which the
immune cells engulf the cargo (microorganism or particulate) as one mechanism of host
defense. Phagocytic innate immune cells such as macrophages and dendritic cells are
capable of phagocytosis as a mode of internalization. They are also capable of performing
other processes of internalization including macropinocytosis and clathrin and
non clathrin-mediated endocytosis [201]. Phagocytosis, which was discovered by Elie
Metchnikoff in 1882, is an internalization process initiated by binding of a
microorganism or particle to phagocytic receptors on cell surface. This binding triggers a
cascade of signaling events inducing cytoskeleton remodeling which allows membrane
movement; consequently, engulfment of the cargo and phagosome formation occurs. The
phagosome is the organelle that contains the cargo. It undergoes a series of events
including fission and fusion with endosomes and lysosomes to ultimately generate
phagolysosome, a process called phagosome maturation [202-204]. The lysosomes
contain a harsh acidic environment due to vacuolar ATPase assembly which is pumping
in protons from the cytoplasm. Also it contains proteolytic enzymes for protein
degradation and peptide generation. The acidic pH denatures the proteins to be easily
degradable by proteolytic enzymes [205]and these conditions favor the generation of
antigenic peptides. In the endoplasmic reticulum (ER), the newly synthesized MHCII is
associated with an invariant chain (Ii) that leads MHCII from the ER to the endocytic
pathway. The invariant chain is cleaved by the proteases in the endosome leaving Class
II-associated Ii derived peptide (CLIP) in the MHCII binding groove. Finally, CLIP is
exchanged by the antigenic peptide with the help of a MHCII like chaperone in the
presence of acidic pH [201].
Effect of TLRs Signaling on Phagocytosis
Toll-like receptors (TLRs) belong to a family of germline-encoded pattern
recognition receptors (PRRs). They detect conserved microbial structures called
pathogen-associated molecular patterns (PAMPs). TLRs are considered as type I
transmembrane glycoprotein receptors made of three domains. The N-terminal
ectodomain which is responsible for recognition of PAMPs; a transmembrane domain;
and the C-terminal intracellular domain that shows homology with IL-1 receptor for that
it is called Toll/IL-1 receptor domain (TIR). The TIR domain interacts with different
adapter proteins such as MyD88 to activate downstream signaling. The stimulation of
MyD88 leads to activation of NFkB signaling and the MAPK (mitogen-activated protein
kinase) pathway which is important for expression of cytokines and chemokines such as
IL-6, TNFD and IL-8. Humans and mice have 10 and 13 different form of TLRs
respectively. TLRs 1-9 are conserved in both species with the absence of TLRs 11, 12,
and 13 in humans and non-functional TLR10 in mice. TLRs are further classified into 2
subgroups based on their localization. For instance, TLRs 1, 2, 4, 5, 6, and 11 are
expressed on the cell surface, while TLR 3, 7, 8, and 9 are expressed in intracellular
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compartments such as endosomes, lysosomes, and endoplasmic reticulum for recognition
of nucleic acids [206].
Although TLRs have been known for their induction of cytokine expression,
several studies examined the effect of TLR signaling on phagocytosis. Blander and
Medzhitov demonstrated that TLRs regulate phagocytosis at different levels [207]. The
authors showed a defect in internalization of E. coli, S. aureus, and heat-killed
S. typhimurium by TLR2/ 4 DKO and MyD88KO bone marrow-derived macrophages
compared to WT counterparts. Furthermore, there was incomplete colocaliztion of GFP
labeled E. coli with a marker for late endosomes and lysosomes indicating a defect in
phagosome maturation [207]. Finally, inhibition of p38 mitogen-activated protein kinase
(MAPK) impaired the ability of macrophages to phagocytose E. coli. [207]. In
conclusion, TLR signaling affects the phagocytosis process.
It was also examined if TLRs signaling can affect antigen presentation as a
subsequent process to phagosome maturation [208]. They found that a phagosome that
carries a microbial cargo, i.e. pathogen binding to TLR, is able to mature to endosomal
and lysosomal compartments and the microbial peptides will have access to MHCII for
peptide-MHCII loading; hence their transportation to cell surface. On the other hand,
phagocytosis of apoptotic cells generate peptides in phagolysosomal compartment;
however, the peptides do not have access to MHCII and consequently the formation of
peptide-MHCII complex is inhibited [208]. In summary, the type of the cargo packed
with TLR in the phagosome can dictate the fate of the phagosome.
Other studies have shown the effect of TLRs on phagocytosis in several bacterial
infections. For instance, in pneumococcal infection, TLR9 and MyD88 deficient alveolar
and bone marrow-derived macrophages develop defects in internalization as well as
bacterial killing compared to WT counterparts [209] showing that TLR signaling is
indispensible for defense against Streptococcus pneumoniae. Furthermore, macrophages
from TLR2 KO and MyD88 KO mice were impaired in L. monocytogenes uptake [210]
After intraperitoneal infection, TLR2KO and MyD88KO peritoneal macrophages have
low numbers of L. monocytogenes compared to WT [210]. In conclusion, TLRs can
affect the phagocytosis process in different bacterial infection models.
Effect of TLRs Signaling on Costimulatory Molecules and Cytokine Expression
As mentioned earlier, both ligation of costimulatory molecules and the
appropriate cytokine milieu are required for differentiation of naïve T cells. Several
studies showed the effect of TLRs not only on phagocytosis but also on the expression of
cytokines and costimulatory molecules [211-213]. For instance, it was demonstrated that
peptidoglycan-associated lipoprotein (PAL) of L. pneumophila is responsible for
induction of proinflammatory cytokines IL-6 and TNFDfrom peritoneal macrophages
through TLR2. Furthermore, the production of IL-6 and IL-12 was enhanced by
costimulation with PAL and CpG ODN as a synthetic stimulus for TLR9. These data
showed that TLRs2 and 9 induce proinflammatory cytokines from peritoneal
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macrophages in a cooperative manner [211]. Additionally, PAL induced cell surface
expression of MHCI and II molecules and costimulatory molecules CD40, 80, and 86.
Also, costimulation with PAL and CpG ODN increased CD80, CD40, and MHCII
expression but not CD86 and MHCI expression when compared to PAL stimulation alone
[211]. In another study, Helicobacter pylori stimulated production of IL-6, IL-8, IL-10,
and IL-12 production from immature human DCs in a dose-dependent manner. There was
also an increase in mean fluorescence intensity (MFI) of CD80, CD83, and CD86 as well
as MHCII [212]. Different species of lactobacillus induce different cytokines such as
IL-6, IL-10, IL-12, and TNFDas well as upregulation of CD86 and MHCII [213]. In
conclusion, signaling through different types of TLRs affects the expression of
costimulatory molecules and cytokines.
The Role of TLRs in Innate and Adaptive Immunity during HP
Previous studies in our lab have shown the crucial role of MyD88 in neutrophil
recruitment and chemokine expression during the innate phase of HP [127]. Our lab
wanted to identify the TLRs upstream of MyD88 that interact with SR. Since SR is a
gram-positive bacterium, in vitro studies demonstrated that TLR2 was the candidate PRR
used by SR [127]. We used TLR2 KO mice to investigate whether SR interact with TLR2
to effect neutrophil recruitment and chemokine expression. TLR2 KO mice had a
decrease in neutrophil recruitment although it did not reach statistical significance
compared to the WT mice exposed to SR. CXCL2 was significantly downregulated in
TLR2 KO adherent splenic cells following in vitro SR stimulation when compared to WT
counterparts [127]. These data demonstrated that while TLR2 contributes to neutrophil
recruitment there is another TLR(s) that also plays a role. One other candidate is TLR9
which is expressed intracellularly in endosomes to recognize CpG motifs in bacterial
DNA. TLR2/9 DKO mice were generated by the lab to investigate if TLR9 cooperates
with TLR2 to control neutrophil recruitment. Previous data in our lab showed that
TLR2/9 DKO mice had a significant reduction in neutrophil recruitment as well as
neutrophil chemokine expression following SR exposure for 6 hours as compared to WT
counterparts. Also, there was a significant reduction in neutrophil chemokine (CXCL2) in
TLR2/9DKO mice following three weeks of SR exposure. In conclusion, both TLRs 2
and 9 affect neutrophil recruitment during HP through regulation of neutrophil
chemokine (CXCL2).
Previous data in our lab also demonstrated that following three weeks of SR
exposure, the frequency of Th17 cells was higher in the lungs of WT mice compared to
TLR2/9 DKO mice. A multitude of factors can control this phenomenon. First, the
inability of DCs in the lymph nodes to polarize naïve T cells efficiently to effector
Th17 cells due to a defect in costimulatory molecules and/or cytokine expression by DCs.
Second, the efficiency of Th17 polarization in the lymph nodes might be equal in both
WT and TLR2/9 DKO mice, but there is a defect in the process of effector Th17 cell
migration from lymph nodes to the lungs of DKO mice. Finally, polarization and
migration of Th17 cells might be equally efficient in both WT and TLR2/9 DKO mice;
however, there could be a defect in antigen presentation capability of antigen presenting
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cells (APCs) in the lungs of TLR2/9 DKO mice where they are unable to stimulate
Th17 cells to produce IL-17 as an effector cytokine. In conclusion, one or a combination
of these scenarios might occur. The aim of this chapter is to determine whether antigen
processing or presentation by TLR2/9 deficient innate immune cells is responsible for the
decrease in IL-17+ CD4 + T cells in the lungs.
METHODS
Animals
Female C57BL/6J WT and MyD88KO mice were purchased from Jackson
Laboratories (Bar Harbor, ME) and used in experiments between 6 – 10 weeks of age.
TLR9 KO mice were originally obtained from Dr. A.K Yi, (Dept. of Pediatrics,
University of Tennessee Health Science Center) and the colony was maintained at
UTHSC. The TLR9 KO mice were crossed with TLR2 KO mice to generate
TLR2/9DKO mice which were bred at the University of Tennessee Health Science
Center and were used in at least 5th generation backcross. Sterile micro-isolator cages
with sterile food and water ad libitum were used for animal housing. All the protocols
were approved by the Institutional Animal Care and Use Committee (IACUC), the
University of Tennessee Health Science Center. All animals were maintained by the
Division of Comparative Medicine at University of Tennessee Health Science Center
according to the guidelines of the animal welfare act.
Antigen Presentation Assay
Isolation of CD4+ T Cells
WT and TLR2/9 DKO mice were exposed to 150ug lyophilized SR for three
weeks. Mice were sacrificed 16-18 hrs following last exposure. BAL was performed
using 10ml of sterile PBS-EDTA (0.1mM) to remove most of the alveolar macrophages
and neutrophils from the air space. Lungs were perfused using 10ml of sterile PBS and
then harvested for collagenase/DNase digestion. Single cell suspension was prepared
using stomacher. Lung total T cells were enriched by an adherence step where cell
suspension was cultured in 100mm petri-dishes. Following 2 hours of incubation at 37°C,
non-adherent cells were collected and the plate was washed once with PBS. CD4+ T cells
were enriched by negative selection method (BD IMag). The purity was usually between
70-80% CD4+ T cells.
Isolation of Adherent Cells
One day before the experiment, spleen cells were harvested from WT and TLR2/9
DKO mice and single cell suspension were prepared using a Stomacher. The cell
suspension from each genotype was cultured in a 100mm petri-dish and incubated at
37°C for 2 hours then adherent cells were harvested. In a 6-well plate, 5x106 adherent
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spleen cells were plated and stimulated with 8x107 CFU of heat-killed SR (HKSR) for 24
hours. Another group of adherent spleen cells were incubated for 24 hours without
HKSR. The reason behind the 24 hours incubation was to give time for the adherent
spleen cells to phagocytose, process, and present SR antigen. Next day (the day of the
experiment), adherent spleen cells were harvested by incubating them with PBS for 15
minutes at 4°C and then washed with media for 3 times to get rid of free unphagocytosed
SR.
Co-Culturing CD4+ T Cells with Unstimulated or Stimulated Adherent Spleen Cells
In a 96-well plate, CD4+ T cells and adherent spleen cells were cocultured at 1:1
ratio. Fig. 4-1 summarizes the antigen presentation assay.
Generation of Bone Marrow Derived Macrophages and Dendritic
Preparation of Bone Marrow Derived Macrophages (BMDMs) Cell Culture Medium
L-929 culture conditioned medium (LCCM) was used as the source of M-CSF
(Macrophage Colony Stimulating Factor) to generate macrophages from bone marrow
in vitro. The L-929 murine fibroblast cell line was obtained from Dr. Ted Strom
(VAMC). The cells were maintained in DMEM containing 10% heat inactivated FCS,
Glutamine (2mM), and penicillin/streptomycin (100U/ml and 100Pg/ml). After 4-5 days,
the culture supernatant was collected and stored at -20°C, and the cells were split into
flasks with a larger surface area. 4-5 days later the supernatant was collected and pooled
with the previous collection. After collecting 1-2 liters of supernatant, the whole
preparation was thawed once then aliquoted into 50ml tubes and stored at -80°C. The
complete conditioned cell culture medium used for generation of bone marrow-derived

Figure 4-1.

Steps for setting up antigen presentation assay.
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macrophages contained DMEM (Cellgro, Mediatech Inc., Manassas, VA) supplemented
with 15% heat inactivated FCS, Glutamine (2mM), Penicillin/Streptomycin (100U/ml
and 100Pg/ml), 50Pg/ml gentamicin (GIBCO cell culture Invitrogen; Carlsbad, CA) and
30% L-929-cell-conditioned medium (LCCM).
Generation of BMDMs
Bone marrow cells were harvested from the tibias and femurs of C57BL/6J,
TLR2/9DKO, and MyD88 KO mice by flushing with sterile PBS. The RBCs were lysed
and the bone marrow cells were washed and suspended in 15ml of complete conditioned
medium. The cell suspension was plated in 100mm non-tissue culture petri-dishes and
incubated at 37°C. The next day, non-adherent cells were collected, counted, and plated
at 5x106 cells/dish in a 100mm petri-dish with 15ml of complete conditioned medium. On
day 3, half of the media was removed and replenished with conditioned medium
containing 60% LCCM. On day 6 or 7, adherent cells were harvested using sterile 1mM
PBS/EDTA for 15 minutes at 37oC, followed by a wash with sterile PBS. Cells were
analyzed by flow cytometry using antibodies to CD11b and F4/80. Macrophages were
identified as CD11b+/F4/80+, and purity was routinely between 80-85%.
Preparation of Bone Marrow Derived Dendritic Cell (BMDCs) Culture Medium
The B16 F10 melanoma cell line was obtained from Dr. Cohen (University of
Kentucky). The cells were transfected with mrGMCSF to be used as a source of
GM-CSF. They were maintained in DMEM containing 10% heat-inactivated FCS,
glutamine (2mM), penicillin/streptomycin (100U/ml and 100Pg/ml), and 2mg/ml G-418
to maintain the transfectants. Once the cells were confluent, they were split into flasks
with a larger surface area till reach confluency. The cells were split again into larger
flasks and grown for 1 week without G418; then they were frozen and used again without
G418 for a maximum of 2 weeks of passage. During this period of time, culture
supernatant was collected and stored at -80°C.
Generation of BMDCs
Bone marrow cells were harvested from the tibias and femurs of C57BL/6J, and
TLR2/9 DKO mice by flushing with sterile PBS. The RBCs were lysed and the bone
marrow cells were washed in media and resuspended in 15ml of complete conditioned
medium. The cell suspension was plated in a 100mm petri- dish. On day 3, 75% of the
media was removed to get rid of neutrophils and replenished with complete conditioned
medium. On day 6-7, non-adherent cells were harvested and dendritic cells were enriched
using a mouse Dendritic Cell Enrichment Kit (BD Biosciences; San Jose, CA) following
the manufacturer’s instructions. The cells were analyzed by flow cytometry using
antibodies to CD11b, CD11c, CD80, and CD86. Immature BMDCs were identified as
CD11b+/, CD11c+/CD80lo/CD86lo.
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Phagocytosis Assays
Preparation of Carboxyfluorescein Succinimidyl Ester (CFSE)-Labeled Lyophilized SR
for in vitro Phagocytosis Assays
A 5mg/ml SR aliquot was washed with PBS twice by centrifugation at 10,000xg
for 5 minutes. The pellet was resuspended in 500Pl sterile PBS and CFSE (Invitrogen,
Carlsbad, CA) was added at a final concentration of 1PM and incubated at 37oC in the
dark. The labeled bacteria were washed 3 times with PBS by centrifugation at 10,000xg
for 5 minutes. The labeling efficiency was measured by flow cytometry and typically
between 80-85% of the bacteria were labeled.
Preparation of TAMRA Labeled Live SR for in vivo Phagocytosis Assays
An aliquot of 40x108 CFU/ml live SR was washed with PBS twice by
centrifugation at 10,000xg for 5 minutes. The pellet was resuspended in 400Pl sterile
PBS then incubated with TAMRA dye (final conc. 12.5Pg/ml) on ice for 10min in the
dark. The pellet was washed with PBS 3 times and then resuspended in 1ml PBS.
Labeling efficiency was checked by microscopy, and it was approximately 90%.
In vitro Phagocytosis
In vitro phagocytosis using flow cytometry: BMDCs or BMDMs were used for
in vitro phagocytosis assays. Ninety Pg/250Pl CFSE labeled SR was opsonized with 8%
normal mouse serum at 37°C. Following 1 hour incubation, the opsonized bacteria were
washed twice with sterile PBS then centrifuged at 10,000xg for 3 minutes. In a 5ml
FACS tube (BD Falcon), 5x105 BMDCs were incubated with the opsonized labeled
bacteria on ice for 30 minutes to allow the binding of bacteria to the cell surface. Tubes
were then incubated at 37oC for 20, 60, 120, 180, or 240 minutes. As a negative control,
10Pg/ml Cytochalasin D (Sigma-Aldrich, St. Louis, MO) was added to inhibit actin
depolymerization and hence phagocytosis. Cells were also incubated with unlabeled SR
at 37°C to gate out fluorescence background and with labeled opsonized SR on ice as
another control. Cells were washed twice with cold PBS to stop phagocytosis then 1ml of
0.4% Trypan blue was added to quench extracellular fluorescence then cells were washed
once with PBS. Finally, the cells were fixed with 100Pl 4% paraformaldehyde (BD
Cytofix™ ) for 15 minute on ice. By gating on live cells using Forward and side scatter,
the percent of BMDCs that phagocytosed labeled SR was measured by flow cytometry.
In vitro phagocytosis using confocal microscopy: In 24 well plate containing
cover slips, WT or TLR2/9 DKO BMDMs (7.5x105 cells/well) were cultured in RPMI
5% FCS for 18 hours to allow adherence. Next day, the cells were incubated with live
opsonized TAMRA labeled SR for 1 hour and 2 hours at MOI 50. For Cytochalasin D
control, certain wells were treated with Cytochalasin D (10PM) for 30 minutes before
incubation with SR. Following incubation times, media were removed and phagocytosis
was stopped by cold PBS then wells were washed to remove free SR. The cover slip was
removed carefully and placed on a glass slide with mounting media (50% glycerol in
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PBS). Each slide contains 3 cover slips representing triplicates from 3 wells. Using LSM
710 confocal microscope, BMDM that contained one or more red dot was counted as one.
Cells that contain any dispersed red speckles were not counted as positive cell. Total cells
in the field were counted then positive BMDMs that internalize SR were counted; finally,
the percentage of BMDMs that phagocytose SR was calculated.
In vivo Phagocytosis
In vivo phagocytosis using flow cytometry: WT and TLR2/9 DKO mice were
exposed to 200Pg of CFSE labeled lyophilized SR. One hour post-exposure the mice
were sacrificed and BALF was collected using 10ml of sterile 1mM EDTA-PBS. The
cells were recovered from the BALF by centrifugation. The cell suspension was
centrifuged for 5min at 1500 rpm then extracellular fluorescence was quenched using 1ml
of 0.4% Trypan blue then incubated for 1 minute at room temp. The cell suspension was
washed with PBS then centrifuged for 5 min at 1500rpm. Finally, the cells were fixed
using 200Pl 4% paraformaldehyde. The percent of alveolar macrophages phagocytosing
labeled SR was measured by flow cytometry. Mice exposed to unlabeled SR were used as
a negative control to gate out fluorescence background.
In vivo phagocytosis using confocal microscopy: WT and TLR2/9 DKO mice
were exposed to 2x108 CFU/50ul TAMRA labeled live SR. One hour post-exposure the
mice were sacrificed and BALF was collected using 10ml of sterile 1mM EDTA-PBS.
The cells were recovered from the BALF by centrifugation and then fixed with 200Pl 4%
paraformaldehyde. The cell suspension was cytospined using cytospin columns for 5min.
at 1500 rpm. The percent of alveolar macrophages phagocytosing labeled SR was
counted using LSM 710 Ziess confocal microscope by merging fluorescent field with
bright field.
In vitro Stimulation of BMDMs Using SR
5x105 BMDMs/well were stimulated with media or 10Pg SR. Following 24 hours
of stimulation, culture supernatant was harvested for detection of cytokines using
Multiplex Sandwich Assay and ELISA.
Multiplex Sandwich Immunoassay
Cytokines in the culture supernatant harvested from stimulated BMDMs were
detected using MILLIPLEX MAP Immunoassay kit (Millipore, Billerica, MA) per
manufacturer’s instructions. The concentration of the cytokine was determined by setting
up standard curves ranging from 3.2 to 10,000 pg/ml. Sample concentrations were
extrapolated from four parameter log standard curve in Milliplex software analyst. The
whole process of cytokine detection using a luminex instrument was done by Dr. Mark
Miller.
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ELISA
Measurement of IFNJ
Mouse IFNJ capture antibody (BD Opt EIA, San Diego, CA) was diluted 1:250 in
coating buffer (0.1M Sodium Carbonate, pH 9.5). In a 96 well plate, 100Pl of the diluted
capture antibody/well was added and incubated at 4oC. Following an overnight
incubation, the plate was washed 5 times with wash buffer (PBS + 0.05% Tween-20);
then the plate was blocked with 200Pl assay diluent (PBS + 10% FBS)/well and
incubated at room temperature. After 1 hour incubation, the plate was washed again.
From the stock standard, 2000pg/ml was prepared as the highest point in the standard
curve; then a 2-fold dilution was prepared from the first concentration, ending with
15.6pg/ml as the lowest concentration. One hundred Pl/well from each dilution was
plated in duplicates and 100Pl/well of the sample was plated as well. The plate was
incubated for 2 hours at room temperature with slow rocking, then washed 5 times.
Working detector was prepared by diluting both Biotinylated anti-mouse IFNJ (BD Opt
EIA, San Diego, CA) (1:250) and streptavidin-horseradish peroxidase conjugate (BD Opt
EIA, San Diego, CA) (1:250) in assay diluent. One hundred Pl of the working
detector/well was added, the plate was sealed, covered, and incubated at room
temperature for 30 minutes. The plate was washed 10 times, soaking the wells with
washing buffer for 1 minute each time. The plate was developed by adding 100Pl/well
TMB substrate (BD Biosciences, San Diego, CA), then incubated for 30 minutes at room
temperature in the dark. To stop the color reaction, 50Pl/well of 2N sulphuric acid was
added. The plate was read on a Spectra Max 340 plate reader (Molecular Devices,
Sunnyvale, CA) at 450 and 570nm to subtract background absorbance. Data was
analyzed by SoftMax® Pro software Version 5 (Molecular Devices, Sunnyvale, CA)
using a 4-parameter standard curve.
Measurement of IL-23p19
Using assay diluent, highest standard concentration (1000pg/ml) was prepared
from the standard stock; then a 2-fold dilution was prepared from the first concentration,
ending with 7.8pg/ml as the lowest concentration. One hundred Pl/well from each
dilution was plated in duplicate, and 100Pl/well of the sample was plated as well into a
96-well plate precoated with anti-mouse IL-23p19. Following 2 hours of incubation at
room temperature, the plate was washed with assay diluent 5 times. Biotinylated antimouse IL-12/23p40 (eBiosciences, San Diego, CA) was diluted 1:250 in assay diluent.
100Pl/well was plated and incubated at room temperature for 1 hour, then washed for 5
times. 100ul of 1:250 diluted streptavidin-horseradish peroxidase conjugate
(eBiosciences, San Diego, CA) was added and incubated in the dark for 30 minutes. After
washing for 7 times with assay diluent, 100Pl/well TMB substrate (eBiosciences,
San Diego, CA) was added; then the plate was incubated for 15 minutes at room
temperature in the dark. To stop the color reaction, 50Pl/well of 2N Sulphuric acid was
added. The plate was read on a Spectra Max 340 plate reader (Molecular Devices,
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Sunnyvale, CA) at 450 and 570nm to subtract background absorbance. Data was
analyzed by SoftMax pro software Version 5 using a 4-parameter standard curve.
Statistical Analysis
Values were expressed as mean ±S.D. For comparison of means between two
populations of unpaired data, unpaired student’s t-test was used. For comparison between
more than two groups, One-way ANOVA followed by Tukey’s post ANOVA test was
used. GraphPad Prism 5 was used to perform all tests. Differences were considered
significant at P <0.05.
RESULTS
TLRs 2 and 9 Did Not Affect Phagocytosis Ability of BMDCs
One explanation for the decrease in Th17 cells in the lung is deficient
phagocytosis of SR by TLR2/9 deficient APCs. To test this hypothesis, we generated
BMDCs in vitro from WT and TLR2/9 DKO mice then incubated them with CFSE
labeled SR at different time points and the internalization of CFSE labeled SR was
measured by flow cytometry. The results revealed that there was no significant difference
in the phagocytosis ability of either WT or TLR2/9 DKO at any time points; both WT
and DKO were able to internalize labeled SR efficiently (Fig. 4-2). We used cytochalasin
D as a control since it inhibits phagocytosis and we did find an inhibition of phagocytosis
using cytochalasin D. We also used serum from C57BL/6J mice exposed to SR for 2
weeks to develop antibodies against SR and use the serum for more efficient opsonization
which will result in more efficient phagocytosis; however, we didn’t find a significant
difference in phagocytosis using immunized or non-immunized serum. In conclusion,
these results demonstrated that TLR2 and 9 did not affect the phagocytosis ability of
BMDCs.
TLRs 2 and 9 Did Not Affect Phagocytosis Ability of BMDMs
We next analyzed events that occur downstream from the polarization of naïve T
cells. Once effector T cells exit lymph nodes after their differentiation, they migrate to
target tissue to perform their effector function (in our model the target tissue is the lung).
Effector T cells require antigen presentation in the target tissue and the candidate cells in
our model were interstitial macrophages.
We hypothesized that interstitial macrophages in TLR2/9 DKO mice were not
efficient in phagocytosis and hence deficient in their antigen presentation ability to
stimulate effector Th17 cells in the lungs. To test this hypothesis, we tried to isolate
interstitial macrophages from WT and TLR2/9 DKO mice but we faced several
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Figure 4-2.
cytometry.

Detection of internalized CFSE labeled SR in BMDCs using flow

One hundred thousand BMDCs were incubated with CFSE labeled SR (360Pg/ml) at
different time points. The percentage of BMDCs phagocytosing labeled SR was
determined using flow cytometry. Each column represents n=3 except 20min time point
was n=2. Results were expressed as means ± SD. Unpaired student’s t-test was used to
compare between WT and TLR2/9 DKO phagocytosis ability within each time point.
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limitations in the isolation technique such as the requirement to pool large number of
mice and low purity. We decided to generate macrophages from bone marrow in vitro
which gave us high yield and purity; therefore, we used BMDMs in phagocytosis assays.
In vitro Phagocytosis Using Flow Cytometry
We designed an in vitro phagocytosis assay using opsonized CFSE labeled SR to
incubate with WT or TLR2/9 DKO BMDMs at different time points. The efficiency of
SR internalization in both WT and TLR2/9 DKO BMDMs was measured by flow
cytometry and then confirmed by confocal microscopy. We started with in vitro
phagocytosis using flow cytometry to determine the best time point to be used next in the
confocal microscopy. As shown in Fig. 4-3, there was not a significant difference at any
time point
In vitro Phagocytosis Using Confocal Microscopy
The phagocytosis results using flow cytometry revealed that both TLR2 and 9 did
not affect SR uptake ability by macrophages; however, these results need to be confirmed
using a different technique. We used confocal microscopy to test if our flow cytometry
results will be confirmed or not. WT or TLR2/9 DKO BMDMs were incubated with
opsonized TAMRA labeled live SR at MOI 50 for one and two hours. Cytochalasin D
was used as a control to inhibit phagocytosis. The internalization of SR was visualized by
confocal microscopy after merging bright with fluorescent field. The phagocytosed
labeled SR was visualized as red dot inside the cell. As shown in Fig. 4-4, there was no
significant difference in phagocytosis ability of WT and TLR2/9 DKO.
TLRs 2 and 9 Did Not Affect Phagocytosis Ability of AMs
The in vitro phagocytosis results from both confocal and flow cytometry
confirmed each other. To confirm the in vitro phagocytosis experiments, we performed in
vivo phagocytosis using AMs. Mice were exposed intranasally to labeled SR. One hour
later, BAL was performed to collect BAL cells. The phagocytosis ability of WT and
TLR2/9 DKO was determined by flow cytometry and confocal microscopy.
In vivo Phagocytosis Using Flow Cytometry
In vivo phagocytosis using AMs was done to confirm in vitro phagocytosis
results. WT or TLR2/9 DKO mice were exposed to CFSE labeled SR. One hour later
BAL was performed to collect BAL cells. The uptake of SR by AMs was measured by
flow cytometry. As shown in Fig. 4-5, both WT and TLR2/9 DKO AMs were able to
phagocytose CFSE labeled SR.
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Figure 4-3.
cytometry.

Detection of internalized CFSE labeled SR in BMDMs using flow

In a 96 well plate, 5x105 BMDMs were incubated with CFSE labeled SR (360Pg/ml) at
different time points. The percentage of BMDMs phagocytosing labeled SR was
determined using flow cytometry. Each column represents n=2. Results were expressed
as means ± SD. Unpaired student’s t-test was used to compare between WT and TLR2/9
DKO phagocytosis ability within each time point.
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Figure 4-4. Detection of internalized TAMRA labeled SR in BMDMs using
confocal microscopy.
Panels (A-P) represent confocal images by merging bright field with fluorescence field.
Panels A and C are representative fields for WT and TLR2/9 DKO BMDMs
phagocytosing TAMRA labeled SR (MOI 50 1 hour) respectively. Panels B and D are
cropped image of the same fields. Panels E-H are same conditions as above except
cytochalasin D was added. Panels I and K are representative fields for WT and TLR2/9
DKO BMDMs phagocytosing TAMRA labeled SR (MOI 50 2 hours) respectively.
Panels J and L are cropped image of the same fields. Panels M-P represents the same
conditions except cytochalasin D was added. Data are representative of 12-15
fields/sample for each condition. (Q) Quantification of phgaocytosis. Each column
represents observation from 9 fields (3 fields/well). Total cells/field was counted then
cells phagocytosing SR were counted to calculate percentage. Results were represented as
means ± SD. Using unpaired student’s test, means between groups incubated with SR and
group treated with Cytochalain D were compared. (***P 0.0001 significant difference
from cytochalasin D control.)
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Figure 4-5.
cytometry.

Detection of internalized CFSE labeled SR in AMs using flow

WT or TLR2/9 DKO mice were exposed to 200Pg of CFSE labeled SR. One hour later
mice were sacrificed and BAL was performed to collect BAL cells. Extracellular
fluorescence was quenched by Trypan Blue, and then washed with PBS. The cells were
fixed with 4% paraformaldhyde, and finally the data was acquired on the flow cytometer.
Each column represents n=8-9 combined from 5 independent experiments. Results were
expressed as means ± SD. Unpaired student’s t-test was used to compare mean between
WT and TLR2/9 DKO phagocytosis percentage.
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In vivo Phagocytosis Using Confocal Microscopy
To confirm the phagocytosis results from the flow cytometry method, we used
confocal microscopy to examine if flow cytometry results match the confocal results.
Both WT and TLR2/9 DKO were exposed to 2x108 CFU/50Pl TAMRA labeled live SR.
One hour later, BAL was performed to collect BAL cells. The BAL cells underwent
cytospin on a glass slide. AMs phagocytosing labeled SR were visualized using confocal
microscopy. As shown in the Fig. 4-6, there was no significant difference in the
phagocytosis ability of both WT and TLR2/9 DKO AMs.
TLRs 2 and 9 Did Not Affect the Antigen Presentation Ability of Splenic APCs
Following T cell differentiation in the lymph nodes, effector T cells migrate to
their target tissues, the site of inflammation; however, they still require antigen
presentation by APCs to maintain their effector function there in. The candidate APCs in
the lung parenchyma are lung interstitial macrophages. Since we observed a decrease in
the frequency of Th17 cells in the lungs of TLR2/9 DKO mice compared to WT
counterparts, we sought to examine the efficiency of WT and TLR2/9 DKO APCs in
stimulating effector Th17 cells to produce IL-17 as effector cytokine.
Phagocytosis is a process that precedes antigen presentation. We already
demonstrated in the previous sections that TLRs 2 and 9 do not affect SR uptake by
macrophages and dendritic cells. Consequently, we examined antigen presentation
efficiency of macrophages using antigen presentation assay.
In this assay, we tested the ability of both WT and TLR2/9 DKO APCs to present
SR antigen to WT or TLR2/9 DKO effector Th17 cells isolated from lungs; and also if
this stimulation of Th17 cells would produce IL-17. The measurement of Th17 effector
function e.g. production of IL-17 is a reflection of the antigen presentation efficiency of
APCs. The assay was set up as described in the methods section.
The results demonstrated that both WT and TLR2/9 DKO CD4+ T cells were able
to produce IL-17 regardless of the phenotype of APCs (WT or TLR2/9 DKO), indicating
that TLR2/9 DKO APCs were equally efficient to present SR antigen to WT or
TLR2/9 DKO CD4+ T cells. In conclusion, these results demonstrated that both WT and
TLR2/9 DKO APCs were equally efficient in SR presentation to WT or TLR2/9 DKO
CD4+ T cells (Fig. 4-7A).
We also used SR lysate as a source of SR soluble antigen to examine if TLRs 2
and 9 affect other internalization pathways than phagocytosis. We cocultured WT or
TLR2/9 DKO CD4+ T cells with WT or TLR2/9 DKO APCs in the presence or absence
of SR lysate. We found that both were able to present SR antigen and hence stimulate
Th17 cells to produce IL-17 as effector cytokine (Fig. 4-7B).
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Figure 4-6. Detection of internalized TAMRA labeled SR in AMs using confocal
microscopy.
WT or TLR2/9 DKO mice (n=3) were exposed to 2x108CFU/50Pl TAMRA labeled live
SR. One hour later mice were sacrificed and BAL was performed to collect BAL cells.
The cells underwent cytospin on a glass slide. Panels (A-D) represent confocal images by
merging bright with fluorescent fields. A and B are WT images while C and D TLR2/9
DKO images. (E) Quantification for 24 fields from 3 mice. Results were expressed as
means ± SD. Unpaired student’s t-test was used to compare between WT and TLR2/9
DKO phagocytosis ability.
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Figure 4-7.
APCs.

TLRs 2 and 9 did not affect antigen presentation ability of splenic

WT and TLR2/9 DKO mice were exposed to SR (150ug) for 3 wks then CD4+ T cells
were isolated with a negative selection kit (BD IMag) from lungs. (A) WT or TLR2/9
DKO CD4+ T cells were incubated with HKSR stimulated WT or TLR2/9 DKO APCs
for 18 hours. As negative control, unstimulated WT or TLR2/9 DKO APCs were
incubated with WT or TLR2/9DKO CD4+ T cells. Following cell surface staining using
anti-CD4 and anti-TCRE antibodies, intracellular cytokine staining for IL-17 and TNFD
was performed. Each bar represent n=4-6. Results were expressed as means ± SD
***P0.0001 and *P<0.02 which is significant difference from the unstimulated control
using unpaired student’s test. (B) WT or TLR2/9 DKO CD4+ T cells were incubated with
WT or TLR2/9 DKO APCs in the presence or absence of SR lysate for 8 hours.
Following cell surface staining using anti-CD4 and anti-TCRE antibodies, intracellular
cytokine staining for IL-17 and TNFD was performed. Each bar represents n=2-3. Results
were expressed as means ± SD *P0.05 and **P<0.01 which is a significant difference
from media control using unpaired student’s test.
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Effect of TLRs 2 and 9 on Cytokine Expression from BMDMs
We hypothesized that cytokines produced by interstitial macrophages play a role
in regulation of the inflammatory environment in the lungs and affect effector function of
the T cells. In order to test this hypothesis, we stimulated BMDMs from WT,
TLR2/9 DKO, and MyD88 KO in vitro with lyophilized SR for 24 hours then we
collected the culture supernatant and measured IL-6, IL-10, IL-12p70, and TNFD using
Multiplex sandwich immunoassay. We also measured IL-23 and IFNJ using ELISA. We
found a significant down regulation in the expression of the proinflammatory cytokines
IL-6 and TNFD as well as the anti-inflammatory cytokine IL-10 from TLR2/9 DKO and
MyD88 KO BMDMs compared to WT stimulated BMDMs. We did not find a significant
difference between WT and TLR2/9 DKO when we measured IL-12p70 however; there
was a significant down regulation in MyD88 KO BMDMs. We didn’t detect IL-23 and
IFNJ using ELISA. In conclusion, TLR2 and 9 and MyD88 down regulate IL-6, IL-10,
IL12p70, and TNFD expression (Fig. 4-8).
DISCUSSION
TLRs 2 and 9 Did Not Affect the Phagocytosis Ability of DMDMs and BMDCs
The process of naïve T cell differentiation to effector CD4+ T cell is crucial for
initiation of adaptive T cell immunity. It requires a combination of sequential processes
take place at different anatomical sites. The first process occurs at the site of infection
where immature DCs, that have a high phagocytic activity, phagocytose the microbial
pathogen. Consequently, DCs undergo a maturation program allowing them to migrate to
the regional lymph nodes and present the microbial antigen to naïve T cells. Therefore,
phagocytosis is an indispensable process for antigen presentation.
Previous results from our lab have shown that following three weeks of SR
exposure, the frequency of Th17 cells in the lungs of TLR2/9 DKO mice was
significantly less compared to WT counterparts. Several possibilities underlie this
observation. One possibility could be deficiency in the capability of TLR2/9 DKO
immature DCs in the lungs to phagocytose the bacteria; hence, there will be a defect in
antigen presentation that will result in impairment in polarization of naïve T cells to
effector Th17. To test this hypothesis, we first measured the phagocytosis ability of WT
and TLR2/9 DKO BMDCs using CFSE labeled SR. The results revealed that there was
not a significant difference in the phagocytosis capability for either WT or TLR2/9 DKO
BMDCs at different time points. This data suggested that both WT and TLR2/9 DKO
BMDCs were equally efficient in phagocytosis.
Next, we planned to measure costimulatory molecules, MHCII, and cytokine
expression using BMDCs. However, we faced several limitations regarding the purity of
BMDCs. We only obtained 40-50% CD11c+ as a marker for DCs. Consequently, we
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Figure 4-8. Expression of IL-6, TNFD, IL-10, and IL-12p70 from WT, TLRs 2/9
DKO and MyD88 KO BMDMs following in vitro SR stimulation.
In a 96 well plate, 5x105 cells/well were plated and stimulated with media or 10Pg SR.
Twenty-four hours later culture supernatant was collected to measure the cytokines using
Multilex sandwich assay. Each bar represents n=4. Results were represented as means
±SD. One way ANOVA followed by Tukey’s post ANOVA test was used to compare the
means of three groups (***P<0.0001). N.D (not detected).
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shifted our efforts to optimize a protocol for isolation of mouse splenic DCs. We obtained
~65% CD11c+ cells but the yield was very low (2-3x105 cells from 2 spleens). As an
alternative way to circumvent these obstacles, we might use mediastinal lymph nodes
(draining lymph node for the lungs) from three weeks SR exposed mice to check
expression of costimulatory molecules and cytokines using intracellular cytokine staining
by gating on dendritic cells. In order to compare results to unexposed mice, we need to
pool a large number of unexposed mice.
As discussed earlier, the defect in factors required for polarization of naïve T cells
by DCs was only one possibility that lies behind the decrease of Th17 frequency in the
lungs of TLR2/9DKO mice. The other possible rational could be a defect in the antigen
presentation capability of lung interstitial macrophages to present SR antigen to effector
T cells. Following polarization of naïve T cells in the lymph nodes, effector T cells
migrate to the site of infection to start their effector function however; they still require
antigen presentation and costimulatory molecules provided by interstital macrophages at
the site of infection. To test if there is a defect in TLR2/9 DKO APCs’ antigen
presentation ability, first we examined their phagocytosis ability as a process that
precedes antigen presentation. We started our initial studies by setting up in vitro
phagocytosis assays using BMDMs. We tried isolating interstitial macrophages from WT
and TLR2/9 DKO but one of the main obstacles was pooling large number of mice. For
that reason, we used BMDMs in the in vitro phagocytosis assays. We found that both WT
and TLR2/9 DKO BMDMs were equally efficient in SR uptake using both flow
cytometry and confocal microscopy techniques. To confirm the in vitro data, we setup in
vivo phagocytosis assays using flow cytometry and confocal microscopy techniques. Our
data demonstrated that WT and TLR2/9 DKO AMs were able to phagocytose SR
efficiently; however, the results of in vivo phagocytosis obtained from flow cytometry
were higher than results obtained from confocal microscopy. There are several reasons
that could explain this difference. One explanation could be a matter of technique
sensitivity, since in the confocal microscopy when we analyzed the data; we set up
certain criteria when counting the cells phagocytosing SR. Only cells with red dots were
counted and any red dispersed speckles were not counted which could be detected by
flow cytometry as a positive signal.
One of the drawbacks of using confocal images by merging fluorescence with the
bright field is proving whether bacterium is intracellular or attached to the cell. We can
tell that labeled SR is inside by looking for the borders of the cell which includes the
cytoplasm and the nucleus; however, SR could adhere to the cell surface and will not be
washed away. Finally, we do not know in which compartment the bacterium resides.
There are a couple ways to circumvent these pitfalls. First, we could label the bacteria
with Oregon green followed by biotin labeling then incubate the biotinylated labeled
bacteria with the cells to allow phagocytosis (1 or 2 hours). Following incubation,
rhodamine-sterptavidin would be added for 30 minutes. If the biotinylated labeled
bacterium is phagocytosed, it will be visualized in the FITC (green) channel only, and if
the bacterium is extracellular or attached to cell surface, it will be visualized in both
channels FITC and rhodamine and appear as yellow on merging between the two
channels. In other words, extracellular or adhered bacterium will be yellow while
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intracellular bacterium will be green on merging between 2 channels. Using lysomal
markers (LAMP1 and LAMP2) could be another way to confirm the internalization of the
bacterium. Both labeled bacterium and cells labeled with lysosomal markers are detected
in different channels. Only internalized bacterium will be visualized by merging between
the two channels.
TLRs 2 and 9 Did Not Affect the Antigen Presentation Ability of Splenic APCs
Following phagocytosis, the antigen is processed to be presented by MHC. We
already tested the phagocytosis ability of both WT and TLR2/9 DKO BMDMs and
BMDCs. As a subsequent process, we will investigate antigen presentation process to
examine if there is a difference in the antigen presentation ability of both WT and
TLR2/9 DKO APCs. If we observe a difference, we will start investigating the steps that
precedes antigen presentation i.e. antigen processing that might lead to a defect in antigen
presentation. A defect in antigen presentation might reflect why we see a decrease in the
frequency of Th17 cells in lungs of TLR2/9 DKO mice.
We hypothesized that TLR2/9 DKO APCs were not able to phagocytose and
hence present SR antigen to effector Th17 cells in the lungs compared to WT APCs that
can phagocytose and present SR antigen to effector T cells. To test this hypothesis, we
already did in vitro and in vivo phagocytosis assays and our results demonstrated that
both WT and TLR2/9 DKO macrophages and dendritic cells were able to phagocytose
SR efficiently. Next we used an antigen presentation assay to examine the ability of both
WT and TLR2/9 DKO APCs to present SR antigen to effector T cells. We used both
HKSR and SR lysate in the antigen presentation assays. Using HKSR, we measured
IL-17 production from CD4+ T cells to test their effector function. If APCs were not able
to present SR to T cells, we will find low percentage of Th17 cells. In order to confirm
the production of IL-17 is actually from antigen specific T cells, one control should be
added to the experiment: coculturing naïve CD4+ T cells with APCs presenting SR
antigen. Since naïve T cells are not antigen specific to SR, we expected to find no
response from naive T cells.
We also used SR lysate to check if TLRs2 and 9 affect other pathways other than
phagocytosis that soluble antigens use to be internalized. Both APCs and T cells were
cocultured together in the presence or absence of SR lysate then IL-17 production was
measured from CD4+ T cells using intracellular cytokine staining. Since there is a
possibility that PAMPs in the SR lysate can stimulate T cells directly to produce
cytokines, one control should be added to the experiment: stimulation of CD4+ T cells
isolated from lungs of mice exposed to SR for three weeks with SR lysate then determine
the production of IL-17 from CD4+ T cells with intracellular cytokine staining. In both
cases (using HKSR or SR lysate), the results demonstrated that both WT and
TLR2/9 DKO APCs were able to present SR antigen efficiently to effector CD4+ T cells
stimulating them to produce IL-17as effector cytokine for Th17 cells. However,
TLR2/9 DKO T cells tend to produce less IL-17 than WT CD4 T cells which requires
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further investigation. One experiment would be stimulation of WT or TLR2/9 DKO
CD4+ T cells with anti-CD3 then measure production of IL-17 by intracellular staining.
Consistently, we observe ~3-4% Th17 cells following antigen presentation assays;
however, Th17 response following three weeks of SR exposure was ~15% in WT mice as
shown in Chapter 2 Fig. 2-7. The discrepancy in the results could be attributed to
differences in experimental setups. We determined Th17 response in the lungs of WT
mice by using total lung cells then stimulated the cells with SR lysate. The total lung cells
already had effector T cells with APCs e.g interstitial macrophages as an example of
efficient antigen presenting cell. On the other hand, in the antigen presentation assay, we
tried to mimic the in vivo environment by incubating splenic APCs with HKSR to
phagocytose, process, and present SR antigen then coculture them with T cells isolated
from lungs. The splenic APCs could be less efficient in antigen presentation since they
are not pure macrophages only. They are contaminated with other cells e.g. B cells which
are less efficient antigen presenting cells. Another possible explanation is the ratio of
APCs to T cells. We used a ratio of 1:1 in the antigen presentation assay. On the other
side, the in vivo situation was different since the ratio of T cells to APCs might be lower
than 1:1(i.e. 1:5, 1:10 or less). In one study, it was determined that the number of antigenMHC complexes required to stimulate effector T cells vs. naïve T cells. It was found that
effector T cells require ~40 antigen-MHC complexes while naïve T cells require ~400
antigen-MHC complexes [214]. To conclude, our studies demonstrated that both WT and
TLR2/9 DKO BMDCs and BMDMs were equally efficient in phagocytosis of labeled
SR. Furthermore, WT and TLR2/9 DKO splenic APCs were capable of SR antigen
presentation and hence stimulation of the Th17 effector function (production of IL-17
from Th17 cells).
These studies led us to think about different alternatives to explain the original
observation that following three weeks of SR exposure, TLR2/9 DKO mice were
characterized by fewer Th17 cells in their lungs compared to their WT counterparts. DCs
are crucial in initiating adaptive immune responses by polarizing naïve T cells in the
lymph nodes. Our studies tested the phagocytosis ability of BMDCs, and we found that
both WT and TLR2/9 DKO BMDCs were equally efficient in up taking labeled SR. We
tried to examine expression of costimulatory molecules and cytokine expression from
BMDCs; however, we faced a number of limitations as mentioned before. We
hypothesized that TLR2/9 DKO BMDCs produce less IL-6 and TGFE (cytokines
required for Th17 differentiation); consequently, they affect differentiation of naïve
T cells to Th17 cells. Another possibility is that differentiation of Th17 cells is equally
efficient in both WT and TLR2/9 DKO lymph nodes, but there is a defect in the
chemokines required for migration of effector Th17 cells from lymph node to the lung.
TLRs 2 and 9 and MyD88 Affect Cytokine Expression by BMDMs
As mentioned before in chapter one, the cross-talk between the cells within the
granuloma regulate the microenvironment. The cytokines produced by macrophages in
the lungs might play a role in regulating effector T cells as well as the cytokine
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environment in the granuloma. Following in vitro SR stimulation, we found a significant
decrease in IL-6 production from TLR2/9 DKO and MyD88 KO BMDMs compared to
WT BMDMs. IL-6 is a proinflammatory cytokine and it is required for Th17
differentiation. IL-6 can also regulate T cell proliferation [215]. IL-6 KO ova specific T
cells were not able to proliferate [215]. Since we already showed that both WT and
TLR2/9 DKO BMDMs were equally efficient in phagocytosis and antigen presentation,
we could hypothesize that the deficiency of IL-6 in the lungs of TLR2/9 DKO might
affect proliferation of SR antigen specific Th17 cells; however, further experiments need
to be done before making this conclusion. We hypothesized that expression of IL-10 from
BMDMs will affect the expression of IL-17 expression from Th17. It has been shown
that IL-10 down regulates IL-17 expression from CD4+ T cells [216]; however, we found
a downregulation in IL-10 from TLR2/9 DKO BMDMs. IL-10 could be expressed by
other cell types in the lungs. Both IL-12p70 and IFNJ cytokines could play a role in the
conversion of Th17 to Th1 cells [171]. Therefore, we might suggest that both cytokines
are responsible for decrease in the Th17 effector cells in the lungs of TLR2/9 DKO mice.
IL-23 is a survival factor for Th17 cells and we didn’t detect it from BMDMs. It might be
another cell population is producing it. We already detect IL-23p19 message from the
lungs of exposed mice following three weeks of SR exposure. As discussed earlier,
TNFD plays an important role in the maintenance granuloma integrity. The significant
decrease in TNFĮ from TLR2/9 DKO BMDMs might explain the dampened the
inflammatory environment in the lungs of TLR2/9 DKO mice. Also, it has been reported
that TNFD, IL-16, and IL-17A stimulates chemokines required for migration of Th17
cells from endometriotic stromal cells [217]. Consequently, TNFD could play an indirect
role in recruitment of Th17 cells into the lungs through induction of chemokines required
for Th17 cells attraction. In conclusion, these results indicated TLRs 2 and 9 play an
important role in the induction of these cytokines from BMDMs.
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CHAPTER 5.

DISCUSSION

HP IS ASSOCIATED WITH A PREDOMINANT TH17 RESPONSE
The results from our studies demonstrated that granulomatous HP was associated
with a Th17 response. Following three weeks of SR exposure (granulomatous HP), we
found a predominant Th17 response associated with granuloma formation. Since we
found Th17 response was predominant during granulomatous HP, we decided to examine
T cell response during chronic HP. Following twenty five weeks of SR exposure, we
found a strong Th17 response. In conclusion our results revealed that both granulomatous
and chronic HP were associated with Th7 response.
Although the results demonstrated that HP was associated with Th17 response,
the studies were only showing a correlation between HP and Th17 response not a cause
and effect relationship. To address the role of Th17 cells in HP, we could adoptively
transfer Th17 cells into RAG-2 KO mice then expose the mice to SR for three weeks.
Finally, we will measure parameters of disease severity such as granuloma formation and
fibrosis. Simonian et al., also reported that HP is associated with Th17 response and they
are required for lung inflammation and fibrosis.
CORRELATION BETWEEN T-BET, DISEASE SEVERITY AND TH17
RESPONSE DURING HP
Despite the fact that Th17 was the dominant response during HP, there were a
small percentage of SR specific Th1 cells in the lungs. However, we were not sure what
is the role of these cells during HP? In our lab, previous studies showed that IFNJ
produced from Th1 cells was not necessary for granuloma formation calling into the role
of Th1 cells. To address the role of Th1 in HP we used T-bet KO mice. Following 3
weeks of SR exposure, we found upregulation in IL-17 mRNA and protein expression in
T-bet KO exposed mice compared to WT exposed mice. Also we found an increase in the
frequency of Th17 cells accompanied by exacerbated peribronchiolar granulomatous
inflammation in T-bet KO exposed mice compared to WT exposed mice. Our findings
were confirmed by other studies in the literature. For example, T-bet KO mice infected
with SEA/CFA showed increase in disease severity accompanied by increase in Th17
cytokines [169]. Furthermore, in T. cruzi mouse infection model there was an increase in
the percentage of Th17 cells from the spleens of T-bet KO mice [170]. In conclusion, our
studies revealed the protective role of T-bet during HP and its inhibitory effect on Th17
response.
Despite the protective role of T-bet and its inhibitory effect on Th17 response
during HP, we did not address the type of the immune cell expressing T-bet that is
responsible for these effects. To fulfill this aim, we could adoptively transfer either WT
or T-bet KO naïve CD4+ T cells into RAG-2 KO mice then expose the mice for three
weeks and measure parameters for disease severity and Th17 response. If we do see the
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same degree of disease severity in both groups, therefore, T-bet in T cells is not
responsible for disease severity. If we find disease severity in the group receiving T-bet
KO T cells is more than mice receiving WT T cells, therefore, T-bet regulate disease
severity in a T cell intrinisic manner. In T. cruzi mouse infection model, T-bet regulates
Th17 development in T cell intrinisic manner. The authors showed the adoptive transfer
of naïve T-bet KO CD4+ T cells into RAG-2 KO enhance expression of IL-17 from CD4+
T cells more than WT transfer to RAG-2 KO mice [170].
EFFECT OF TLRS 2 AND 9 ON TH17 RESPONSE DURING HP
The results from the previous two sections revealed that HP was associated with a
predominant Th17 response and T-bet controls Th17 response and disease severity during
HP. Consequently, we were looking for other factors that could regulate Th17 response
during HP and we came across the following observation from previous studies in our
lab. Following three weeks of SR exposure, the frequency of Th17 cells was fewer in the
lungs of TLR2/9 DKO mice compared to WT mice. We were investigating the reason
behind this observation and we found several possibilities that can be hypothesized. We
tested one possibility which was inability of antigen presenting cells (APCs) to present
SR antigen to effector T cell in the lungs of TLR2/9DKO. Since antigen presentation
starts with the uptake of the bacteria, we tested first the phagocytosis ability of WT and
TLR2/9 DKO APCs in vitro and in vivo. Our results revealed that both WT and TLR2/9
DKO BMDMs or BMDCs were capable of SR uptake in vitro. To confirm the in vitro
studies, we performed in vivo phagocytosis to test the phagocytosis ability of alveolar
macrophages using labeled SR. The data have demonstrated that both WT and TLR2/9
DKO alveolar macrophages are equally efficient in phagocytosis. In conclusion these
results showed that absence of TLRs 2 and 9 does not affect the phagocytosis ability of
APCs. Next we examined the antigen presentation ability of WT and TLR2/9 DKO APCs
to check if they were capable of presenting SR antigen to effector Th17 cells. We found
that both WT and TLR2/9 DKO APCs were equally efficient in presenting SR antigen to
WT and TLR2/9 DKO effector T cells. In summary, TLRs 2 and 9 did not have an effect
on antigen presentation ability of the APCs.
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CHAPTER 6.

CONCLUDING REMARKS

HP is a T cell-mediated disease and several studies have shown the pathogenic
role of T cells during HP. Consequently, our studies were focused mainly on determining
the type of T cell response and unraveling some of the factors that might control T cell
response during HP. Targeting these factors might be a potential future therapy for HP.
An overall summary for our studies is depicted in Fig. 6-1. Once SR is inhaled, it
stimulates lung immune and non-immune cells to produce cytokines and chemokines in
MyD88-dependant fashion. CXCL1 and CXCL2 are chemokines required for neutrophil
recruitment. Following the first wave of cytokines and chemokines, neutrophils were
recruited into the airways. Neutrophils were considered as a crucial source of IFNJ
which is required for granuloma formation in this model. Our studies demonstrated that
neutrophils produce IFNJ in an IL-12/IL-18, or IL-15/IL-18-dependant manner.
Dendritic cells can sense SR in the airways by their dendrites. Consequently, they
undergo a maturation process and migrate to lymph nodes, starting polarization of naïve
T cells into effector T cells. We found that the predominant T cell response in the lungs
during HP was a Th17 response with minimal Th1 response. We also found that T-bet
regulates Th17 response as well as granuloma formation during HP. Therefore, we
consider T-bet one of the factors that regulates Th17 response as well as granuloma
formation and lung fibrosis. Based on these results, we might consider T-bet as a
therapeutic target for HP treatment. Polymorphisms in T-bet could explain why some
patients develop fibrosis while others do not. Sequencing T-bet from a number of HP
patients at the chronic stages and comparing them to patients at granulomatous stages as
well as normal subjects could give us insights into how T-bet polymorphisms decide the
fate of HP.
We also found from previous studies in our lab that TLRs control the Th17
response during granulomatous HP; however, the mechanism(s) behind this control is
still under investigation. So far we found that TLR2 and 9 did not affect the phagocytosis
ability of macrophages and dendritic cells. Furthermore, TLRs2 and 9 did not affect the
antigen presentation ability of APCs. Even though we still lack the exact mechanism of
controlling Th17 response by TLR2 and 9, that doesn’t eliminate the idea of TLRs as
therapeutic targets. Again TLRs polymorphisms could play a role in the severity of HP.
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Figure 6-1.

Overall HP model.

SR stimulates AMs and probably other cells in the airways to produce different
chemokines and cytokines that recruit neutrophils into airways. SR also could be detected
by DCs which consequently migrate to lymph nodes to initiate polarization of naïve T
cells into effector Th17 cells. Th17 effector T cells migrate to the lungs for granuloma
formation. T-bet inhibited both Th17 development and granuloma formation. Both WT
and TLR2/9 DKO APCs were able to present SR antigen to Th17 cells, stimulating IL-17
production from Th17 cells.
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